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ABSTRACT  
Rosette formation is one of the unique biological phenomena that have been linked to 
pathobiology of malaria. It is believe to be associated with the severe outcomes of 
falciparum malaria. Most of the knowledge about rosetting is obtained from in-depth 
studies conducted on Plasmodium falciparum. However, the rosetting phenomenon and 
pathobiology of vivax malaria is not well studied. This research project aimed at 
deciphering the unknown aspects behind rosetting phenomenon of P. vivax, and 
investigating the role of rosette formation in pathobiology of vivax malaria. In total, 121 
fresh P. vivax isolates, 48 cryopreserved P. vivax isolates, 122 fresh P. falciparum 
isolates and 5 cryopreserved P. falciparum isolates were recruited into this research 
project. A novel technique suitable for reticulocyte characterization and rosetting assay 
in field setting was developed from this research project. Based on the field studies 
conducted, rosette formation is common in P. vivax. However, rosetting is not 
significantly correlated to clinical parameters such as reticulocyte count and 
parasitaemia. Besides, cryopreservation and thawing processes affect the rosetting 
capability of P. vivax isolates. Rosette formation was found to be initiated at the early 
trophozoite stage of P. vivax and the rosetting development reached plateau at the end 
of the erythrocytic maturation. Giant rosettes were found more frequently in P. vivax 
than P. falciparum. In addition, gametocytes were found to be involved in rosette 
formation. Unlike P. falciparum, the rosetting phenomenon of P. vivax is independent 
of human ABO blood groups and complement receptor 1 (CR1/CD35). However, 
rosetting phenomena of P. vivax and P. falciparum are dependent on the BRIC4 region 
of human glycophorin C (CD236R), strongly indicating the BRIC4 region of CD236R 
as another rosetting coreceptor for P. vivax and P. falciparum. On elucidating the roles 
of rosette formation in pathobiology of malaria, the significantly high preference for 
normocytes instead of reticulocytes in rosette formation clearly shows that rosetting is 
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unlikely to assist merozoite reinvasion in vivax malaria. Furthermore, increased 
rosetting rates upon exposure to anti-malaria drug compounds and human white blood 
cells suggest that the rosetting phenomenon may serve as an intrinsic protective 
mechanism of the malaria parasites against their environmental threats. 
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ABSTRAK 
Pembentukan rosette merupakan salah satu fenomena biologikal yang telah dikaitkan 
dengan patobiologi malaria. Fenomena ini dipercayai berkaitan dengan keparahan 
penyakit malaria. Kebanyakan ilmu pengetahuan tentang pembentukan rosette telah 
diperoleh dari kajian-kajian yang mendalam terhadap Plasmodium falciparum. Namun 
demikian, fenomena pembentukan rosette and patobiologi vivax malaria kurang dikaji 
and diketahui. Project ini berobjektif untuk menyiasat soal-soal tentang pembentukan 
rosette oleh P. vivax, dan peranan yang dimain oleh rosette dalam patobiologi vivax 
malaria. Secare keseluruhannya, 121 sampel segar P. vivax, 48 sampel pepbekuan awet 
P. vivax, 122 sampel segar P. falciparum dan 5 sampel pembekuan awet P. falciparum 
telah digunakan dalam projek kajian ini. Sebuah teknik baru untuk pengiraan korpuskal 
merah muda (reticulocyte) dan eksperimen rosette yang sesuai digunakan dalam kerja 
lapangan telah dihasilkan menerusi projek ini. Berdasarkan projek ini, fenomena 
pembentukan rosette adalah biasa di kalangan P. vivax. Namun begitu, pembentukan 
rosette tidak berkaitan langsung dengan parameter klinikal seperti kiraan reticulocyte 
and parasitemia. Selain itu, proses pembekuan awet and pemanasan sel menjejaskan 
keupayaan P. vivax untuk membentuk rosette. Kejadian pembentukan rosette bermula 
pada tahap trophozoite awal dan berkembang sehingga mencecah tahap tepu pada tahap 
akhir proses permatangan dalam darah. Rosette gergasi telah ditemui dengan lebih 
banyak di P. vivax berbanding dengan P. falciparum. Selain itu, gametocyte juga 
terlibat dengan proses pembentukan rosette ini. P. vivax didapati berbeza dengan P. 
falciparum di mana pembentukan rosettenya tidak bergantung pada kumpulan ABO 
darah manusia dan reseptor complement 1 (CR1/CD35). Pembentukan rosette P. vivax 
dan P. falciparum didapati bergantung pada bahagian BRIC4 glycophorin C manusia 
(CD236R). Dengan ini, bahagian CD236R dipercayai memainkan peranan penting 
sebagai satu lagi reseptor sampingan pembentukan rosette untuk P. falciparum dan P. 
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vivax. Bagi kajian mencari peranan rosette dalam malaria, adalah didapti bahawa 
korpuskal merah dewasa (normocytes) lebih dipilih untuk pembentukan rosette 
berbanding dengan reticulocyte. Dengan ini, jelaslah bahawa pembentukan rosette tidak 
membantu penjangkitan baru merozoite P. vivax. Lebih-lebih lagi, peningkatan tahap 
pembentukan rosette semasa pertembungan dengan ubat anti-malaria dan korpuskal 
putih manusia mencadangkan bahawa pembentukan rosette merupakan satu tindakan 
pertahanan diri oleh parasite daripada unsur-unsur merbahaya di keliling mereka.  
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INTRODUCTION 
1.1 History of malaria 
Malaria is one of the oldest infections that have been plaguing mankind for 
centuries. Records about malaria can be traced back to thousands of years ago in 
medical writings, such as the Yellow Emperor’s Inner Classic (Huang Di Nei Jing) from 
ancient China (CDC, 2010a). Malaria is believed to be responsible for the deterioration, 
and hence the fall of the Roman Empire (Thompson, 2011). This infection was also one 
of the major life-threatening challenges encountered during the construction of the 
Panama Canal (Darling, 1910; Chamberlain, 1929). Malaria has been successfully 
eradicated from many parts of the world, especially the developed countries of the 
temperate region. Nevertheless, the loss brought by this disease, be it lives or socio-
economical progress, is still catastrophic in many developing countries, especially those 
in Africa (Sicuri et al., 2013). 
 
To date, six distinct Plasmodium species are responsible for human malaria 
transmission, namely Plasmodium falciparum, P. vivax, P. malariae, P. knowlesi, P. 
ovale wallikeri, and P. ovale curtisi. All these medically important malaria parasites are 
transmitted to humans by female Anopheles mosquitoes. In general, these parasites have 
similar life cycle (Figure 1.1), except for the development of the dormant liver stage 
called hypnozoites (Figure 1.2). Only P. vivax and P. ovale spp. can form this dormant 
stage within the human host, which is responsible for the relapses of malaria (Wahlgren 
& Perlmann, 1999; Garcia, 2001; Mueller et al., 2009 Nolder et al., 2013). Humans 
serve as the intermediate hosts of the parasites while the Anopheles mosquitoes serve as 
the definitive hosts. As P. knowlesi is a zoonotic parasite, long-tailed macaque monkeys 
and pig-tailed macaque monkeys are the natural intermediate hosts. 
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Figure 1.1  Life cycle of Plasmodium spp. (Diagram source: CDC, 2010b) 
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Figure 1.2 Life cycle of P. vivax and P. ovale spp., highlighting hypnozoite 
development in human liver. (Diagram source: Mueller et al., 2009) 
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1.2 Clinical complications of malaria 
Individuals with malaria usually show signs and symptoms that include fever 
paroxysms, rigors, myalgia, arthralgia, sweating, loss of appetite, diarrhea, fatigue, 
hepato-splenomegaly, and coughing. Some of the clinical presentations of malaria are 
similar to many other tropical infections. Therefore, malaria may be misdiagnosed upon 
admission, especially in non-malaria endemic regions. 
 
Malaria may lead to various forms of clinical complications. The most 
noteworthy complication is cerebral malaria. This form of severe malaria is caused 
almost exclusively by P. falciparum (Trampuz et al., 2003). Consquently, P. falciparum 
was wrongly perceived as the only malaria parasite that can cause potentially fatal 
“malignant malaria” (Galinski, 2008; Mueller et al., 2009). Severe complications, 
sometimes with fatal outcome, can be caused by other malaria parasites as well. Severe 
malaria can manifest in the form of acute respiratory distress syndrome (ARDS), acute 
kidney injury (AKI), splenic rupture, hypoglycaemia, placental malaria, hypotension 
and shock, thrombocytopaenia, hyperparastiaemia, as well as severe anaemia (Martell et 
al., 1979; Lee et al., 1999; Tanois et al., 2001; Prakash et al., 2003; Trampuz et al., 
2003; Lomar et al., 2005; Anstey et al., 2007; Uneke et al., 2007; Cox-Singh et al., 
2008; Das, 2008; Mohan et al., 2008; Rojo-Marcus et al., 2008; Thapa et al., 2009; 
Lacerda et al., 2011; Deroost et al., 2013; Hachimi et al., 2013; Lau et al., 2013; Lee et 
al., 2013a). 
 
1.3 Rosetting phenomenon in malaria 
Malaria causes substantial changes to the host’s infected erythrocytes. Rosette 
formation is one of such well-known phenomena (Roberts & Janovy, 1999; Garcia, 
2001). Rosetting in malaria is defined as a phenomenon where an erythrocyte infected 
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with Plasmodium spp. binds to at least two uninfected erythrocytes (David et al., 1988) 
(Figure 1.3). This phenomenon is observed in various species such as P. falciparum, P. 
vivax, P. ovale, and P. malariae (David et al., 1988; Udomsangpetch et al., 1995; 
Angus et al., 1996; Lowe et al., 1998; Rahman et al., 2010). Rosetting phenomenon, 
along with deep vein sequestration, places malaria as a disease unique from other 
infections that show similar clinical presentations. 
 
Since its discovery in the late 1980s, rosette formation has been associated with 
clinical complications seen in falciparum malaria (David et al., 1988; Udomsangpetch 
et al., 1989; Hasler et al., 1990; Udomsangpetch et al., 1992; Wahlgren et al., 1992; 
Breman, 2001; Sherman, 2005). Rosetting is believed to play important roles in the 
pathogenesis of malaria (Wahlgren et al., 1989; Sherman, 2005). This phenomenon is 
postulated to assist deep vein sequestration in inducing mechanical occlusion of 
vasculature. Besides, rosetting is believed to play roles in immuno-evasion mechanisms 
of malaria parasites. In addition, this biological event is postulated to enhance 
merozoites reinvasion upon the rupture of schizont. 
 
Until now, these postulated roles have not been validated. Furthermore, the 
postulated roles of rosetting werre put forward based on the falciparum malaria model. 
Therefore, these roles may not be applicable to malaria caused by other species of 
malaria parasites.  
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Figure 1.3 A schematic diagram showing a rosette formed by a Plasmodium- 
infected erythrocyte. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
infected erythrocyte 
uninfected erythrocytes 
malaria parasite 
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1.4 Rosetting phenomenon in vivax malaria 
In contrast to the numerous observations of rosetting in P. falciparum, 
information on the basic properties of rosettes formed by P. vivax-infected erythrocytes 
is scarce. P. vivax has been overshadowed by P. falciparum for a very long time on the 
arena of malaria research, creating a huge knowledge gap between the two species 
(Galinski & Barnwell, 2008; Mueller, 2009). As a result, many properties of this second 
most prevalent malaria pathogen are predicted by extrapolation from findings in P. 
falciparum. However, different species of parasites may behave differently, making 
deductions of biological properties based on findings from another species difficult and 
sometimes, of limited significance. 
 
A better understanding on the biological properties of a parasite contributes to 
the deciphering of puzzles behind the parasite’s pathogenesis. Hence, there is a need to 
devote greater attention to rosetting properties of P. vivax. In addition, the postulated 
roles of rosetting must be tested to elucidate its actual role(s) played in malaria. A better 
characterization and comparison of this unique phenomenon in both P. falciparum and 
P. vivax will be beneficial for the understanding of the pathobiology of these parasites. 
 
1.5 Objectives 
Based on the goal of deciphering unknown aspects behind rosetting 
phenomenon of P. vivax, this research project carried four objectives as elaborated 
below. 
 
1.5.1 Development of a better technique for haematological investigations 
This research project aimed at developing an improved, cheaper and more 
convenient method for visualization and characterization of rosetting events. There is an 
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obvious need for an improved method to compensate the flaws or disadvantages posed 
by the current routine techniques. At the same time, this research project also aimed at 
developing an easier and more accurate alternative for reticulocyte profiling on malaria-
infected samples, which can be used in parallel with the rosetting characterization. 
 
1.5.2 Characterization of rosetting properties of P. vivax 
The basic biological properties of rosette formation in P. vivax were investigated. 
These encompassed time course rosetting development of the parasite along its 
erythrocytic stage maturation, effect of cryopreservation on rosetting capability of the 
vivax malaria isolates, rosetting prevalence, and relationship of rosetting event with 
different clinical parameters of the vivax malaria isolates. Besides, this research project 
also aimed at identifying the receptors needed by P. vivax to form rosettes.  
 
1.5.3 Comparison of rosetting properties between P. vivax and P. falciparum. 
The data collected from the experiments conducted during this research project 
were also used to compare and contrast the rosetting properties of P. vivax and P. 
falciparum. The similarities and differences of rosetting events between the two species 
were highlighted. Such comparison would serve as a better reference for predicting and 
extrapolating rosetting properties of other medically important malaria parasites. 
 
1.5.4 Investigation of the roles played by rosetting event in malaria 
Another goal of this research project was to decipher the actual role(s) played by 
rosette formation in the course of P. falciparum and P. vivax infection. Instead of 
creating new hypotheses, the current postulated roles of rosetting were tested, in the 
hope of finding the actual role(s) that this biological phenomenon has in the 
pathogenesis of malaria. 
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LITERATURE REVIEW 
2.1 Plasmodium vivax 
Plasmodium vivax is the aetiological agent of the so-called “benign tertian 
malaria”. P. vivax has the widest geographical distribution among the human malaria 
parasites (Roberts & Janovy, 1999; Garcia, 2001; Mendis et al., 2001; Mueller et al., 
2009; MAP, 2012). It is also the most prevalent aetiological agent of malaria in 
temperate regions (Mendis et al., 2001) (Figures 2.1 & 2.2). Usually, P. vivax infections 
are accompanied with parasitaemias that are relatively lower than those of P. falciparum 
infection, due to the parasites’ high preference to invade reticulocytes (Hegner, 1938; 
Kitchen, 1938; Russell et al., 2011). Besides, P. vivax is believed to show selective 
invasion of Duffy-positive reticulocytes (Miller et al., 1976; Ranjan & Chitnis, 1999; 
Roberts & Janovy, 1999; Garcia, 2001). However, this species seems to have evolved 
and adapted to alternative invasion mechanisms. Recently, Duffy-negative patients in 
Africa and South America with mono-infection of P. vivax were reported (Cavasini et 
al., 2007; Ménard et al., 2010, Mendes et al., 2011). 
 
Until recently, P. vivax was presumed by many as non-fatal or “benign” (Price et 
al., 2007; Galinski & Barnwell, 2008; Mueller, 2009; Gething et al., 2010). However, 
severe vivax malaria complications in the forms of ARDS, severe anaemia, AKI, and 
placental dysfunction have been documented (Yale et al., 1993; Islam et al., 1995; 
Torres et al., 1997; Pukrittayakamee et al., 1998; Curlin et al., 1999; Lomar et al., 2005; 
Anstey et al., 2009; Anstey et al., 2012; Marín-Menéndez et al., 2013; Patel et al., 
2013). Besides, deaths from vivax malaria have been reported from time to time 
(Jayavanth & Bock, 2007; Anstey et al., 2009; Patel et al., 2013). Furthermore, there are 
many unreported cases in malaria endemic regions. Therefore, one can confidently state 
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that the mortality and fatality of P. vivax infection has been overlooked and 
underestimated. 
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Figure 2.1 The spatial limit of global P. falciparum transmission in 2010 (diagram 
source: MAP, 2012). 
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Figure 2.2 The spatial limit of global P. vivax transmission in 2010 (diagram source: 
MAP, 2012). 
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Through the years, malaria was perceived by many as “a single infection”. 
Regardless of the aetiological agents, the parasite’s cellular biology, clinical spectrum, 
host immunological responses, and the epidemiology of malaria were believed to be the 
same. It was then assumed that by focusing research on P. falciparum and extrapollating 
the knowledge to other species of human malaria parasites, would help malaria control; 
with successful malaria treatment and control strategies leading to eradication. However, 
it it now clear that such assumptions were erroneous (Bockaire et al., 2006; Andrade et 
al., 2010; Baird, 2010; Gething et al., 2010).  
 
A good portrayal of the significant differences between P. falciparum and P. 
vivax is seen in the effort to eradicate malaria. There was a dogma that a single plan of 
malaria eradication would be suitable for all species of malaria parasites (Baird, 2010). 
Most of the malaria control and eradication programs are crafted based on knowledge 
gained from studies on P. falciparum alone. Following the implementation of such 
programs, the number of falciparum malaria cases decreased drastically. However, 
vivax malaria cases in these areas have been noted to oscillate at a relatively stable level 
throughout the implementation of malaria control program (Gething et al., 2010). Such 
a trend has been noted in Myanmar, Cambodia, Laos, Bangladesh, Nepal, Vietnam and 
Malaysia (WHO, 2012) (Figure 2.3). Obviously, the anti-malaria strategy for P. 
falciparum does not fit the war against vivax malaria. Hence, it would be more 
appropriate to re-define “malaria” as “a collection of pathological changes caused by 
different parasites” (Coggeshall, 1952; Baird, 2010). 
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Figure 2.3 Plots showing annual report of malaria cases from selected countries 
of Southeast Asia and South Asia region since year 2000 (crude data sourced from 
World Malaria Report 2012).  
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Figure 2.3, continued Plots showing annual report of malaria cases from 
selected countries of Southeast Asia and South Asia region since year 2000 (crude 
data sourced from World Malaria Report 2012). Twelve countries were selected for 
analysis based on their relative proximity to Malaysia and relative socioeconomic 
interaction with Malaysia. 
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 It is understandable that P. falciparum was given more attention and research 
priority decades ago due to the higher fatality it causes. Owing to the hard work and 
efforts invested, the transmission of falciparum malaria has been successfully controlled 
and eradicated from many parts of the world. Since P. vivax has been shown to be a 
parasite that behaves differently from P. falciparum, coupled with its wide geographical 
distribution and prevalence, P. vivax should no longer be under-appreciated. More in-
depth knowledge about the parasite is required to devise and carry out efficient plans for 
the eradication of vivax malaria, as well as malaria caused by other Plasmodium species. 
Therefore, more attention should be allocated to cellular biological studies of malaria 
parasites other than P. falciparum, though many puzzling biological aspects of P. 
falciparum remain unsolved after being studied intensively for so many years (Dondorp 
et al., 2000). Needless to say, such situation is even worse for P. vivax, especially with 
respect to certain specific biological properties such as the rosetting phenomenon. 
 
2.2 Rosetting phenomenon and malaria severity 
The rosetting phenomenon has been suggested as a marker of severe malaria 
development (Carlson et al., 1990a, Ringwald et al., 1993; Newbold et al., 1997; Rowe 
et al., 2007). A few studies were conducted to determine relationship between rosette 
formation of P. falciparum and cerebral malaria. However, these studies gave 
conflicting results and conclusions (Carlson et al., 1990a; Treutiger et al., 1992; al-
Yaman et al., 1995; Rogerson et al., 1996; Sherman, 2005), suggesting that rosetting is 
not the sole key factor responsible for severe symptom presentation in falciparum 
malaria. Nevertheless, the different experimental techniques and settings applied in 
these studies may lead to variations in the findings. More importantly, the correlations 
in these investigations were derived using cross sectional study design, which provides 
data and information in a “snapshot” mode. Such a model is good for deducing 
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correlation between a well-defined parameter and a well-defined disease outcome. 
However, it is difficult to set a non-subjective, “clear-cut” standard in defining disease 
severity. In addition, the results obtained from such a study design may not reveal the 
actual time-course development of an infection’s pathogenesis, such as severe outcomes 
of the infection. Besides, any correlation found from such a study may not reflect causal 
relationship. These considerations may account for the differences of findings among 
these studies. 
 
2.3 Roles of rosette formation in vasculature occlusion of falciparum malaria 
 As mentioned previously, the binding of parasitized erythrocytes to vasculature 
endothelial cells (sequestration) and the non-infected erythrocytes (rosette formation) 
have long been associated with severe outcomes of malaria (David et al., 1988; 
Udomsangpetch et al., 1992). Both these events are believed to be responsible for the 
deep vasculature occlusion seen in falciparum malaria (Chen et al., 2000; Adams et al., 
2014) (Figure 2.4). Vasculature occlusion can be of mechanical and immunological 
origin. Sequestration and rosetting are believed to be responsible for the mechanical 
occlusion of deep vasculature. 
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Figure 2.4 A schematic diagram showing the dynamics of cytoadhesion 
properties of P. falciparum, which include rosette formation and sequestration. 
(Diagram source: Chen et al., 2000). 
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Sequestration of infected erythrocytes decreases the lumen diameter of the 
affected vasculature, causing interruption of blood flow. Still, the blood flow may not 
be completely blocked. However, with rosette formation, the effect of blood flow 
disruption and blockade may be exaggerated. Rosettes can withstand a certain degree of 
shear force (Nash et al., 1992), resulting in the disruption of the erythrocyte aggregates 
in the artery, but not in the veins, venules or capillaries that have much lower flow rates 
and shear forces. Hence, the presence of rosettes in a vasculature that is already 
narrowed by layers of sequestered parasitized erythrocytes will further impede the 
circulation; subsequently increasing the risk of vasculature occlusion. In addition, the 
blockade of blood flow in small capillaries is further augmented by the decreased 
membrane deformability of the patient’s infected erythrocytes, as well as the non-
infected erythrocytes (Cranston et al., 1984; Nash et al., 1989; Dondorp et al., 1997; 
Paulitschke & Nash, 1993). Erythrocytes with decreased deformability will not be able 
to move through narrowed capillaries as easily as the erythrocytes with normal 
deformability. In short, rosetting and sequestration phenomena are believed to work 
synergistically in causing vasculature occlusion in falciparum malaria patients. 
 
Among the severe complications that are linked to vasculature occlusion, 
cerebral malaria is definitely one of the most important. When the mechanical blockade 
occurs in the small capillaries of brain, it results in highly fatal cerebral malaria 
(Planche et al., 2005). Due to vasculature blockade, oxygen supply to the affected brain 
areas is compromised, causing immediate necrosis of the oxygen-sensitive brain cells. 
Apart from cerebral malaria, placental malaria and alveolar injury are other 
complications related to sequestration and rosetting. These events result in hampered 
utero-placental circulation and pulmonary function, respectively (Vásquez & Tobón, 
2012; de Moraes et al., 2013; Rashidi & Roullet, 2013). Different strains of P. 
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falciparum show variable tendency of developing different complications. It has been 
shown that the strains of P. falciparum isolated from pregnant women and those 
isolated from children show different cytoadhesion affinities to different receptors 
(Beeson et al., 1999). Clearly, different strains of P. falciparum vary in their preferred 
site of sequestration (Dondorp et al., 2000). 
 
2.4 Roles of rosette formation in immuno-evasion of P. falciparum 
Rosette formation in malaria is also hypothesized to play a role in immuno-
evasion of the malaria parasites (Sherman, 2005). Various parasite neo-antigens are 
expressed on the surface of infected erythrocytes, making these infected erythrocytes 
targets for antigen presentation and recognition. Rosettes may act as a “shield of host’s 
antigens”, protecting the parasite’s antigens on the infected erythrocytes from being 
recognized by the antigen presenting cells. Theoretically, rosette formation may hinder 
phagocytosis as well. Such protective mechanism will assist malaria parasites to survive, 
develop and replicate within the host. There is no supportive evidence for this particular 
hypothesis up till now. Nevertheless, in Parasitology, masking host’s immuno-
recognition with host’s own antigens has already been demonstrated, exemplified by 
Schistosoma mansoni that acquires human blood group antigens and human low density 
lipoprotein (LDL) as camouflage (Goldring et al., 1976; Chiang & Caulfield, 1989).  
 
It is interesting to note that apart from contributing to vasculature occlusion and 
deep vein sequestration, the rosetting-related phenomenon is also viewed as an 
immuno-evasion strategy for P. falciparum to avoid splenic clearance of the human 
hosts (Miller, 1969). Sequestration of P. falciparum is mediated by the P. falciparum 
erythrocyte membrane protein 1 (PfEMP1) (Baruch et al., 1995; Su et al., 1995; Adams 
et al., 2014), which is the key player in rosette formation as well. Various membranous 
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changes happen on the infected erythrocyte with the addition of parasite’s antigens onto 
the host erythrocyte membrane. Such antigens of parasitic origin include the ring-
infected erythrocyte surface antigen (RESA) and the PfEMP1 (Chotivanich et al., 2002). 
Hence, the erythrocytes infected with P. falciparum will show significant decrease in 
deformability as the parasites develop into mature stages (Cranston et al., 1984; Nash et 
al., 1989; Paulitschke et al., 1993). Consequently, these relatively rigid erythrocytes 
will not be able to pass through the spleen’s cords of Billroth during splenic filtration, 
and will be retained from re-entering circulation and subsequently destroyed by the 
effector cells (Klausner et al., 1975). By staying within the deep vasculature, owing to 
the parasite’s sequestration and rosetting ability, erythrocytes with mature parasites will 
not be available in peripheral circulation, thus escaping splenic clearance. 
 
2.5 Roles of rosette formation in enhancing P. falciparum merozoite reinvasion 
In addition, rosetting is thought to enhance merozoite reinvasion upon rupture of 
schizont. Based on this hypothesis, the participating uninfected erythrocytes in rosetting 
complex provide convenience to the released merozoites by offering new uninfected 
erythrocytes that are ready for invasion. Merozoites released from the ruptured schizont 
will be able to find targeting host erythrocyte easily without the danger of moving for a 
long distance, thus reducing the risk of being phagocytosed by the host’s phagocytes. 
As a result, the probability of successful merozoite reinvasion will be much higher 
compared to condition without rosette formation. This hypothesis is supported by 
finding that showed positive correlation between rosetting rate and parasitaemia of 
falciparum malaria isolates (Rowe et al., 2002). Nevertheless, there are findings against 
this hypothesis as well (Clough et al., 1998; Deans & Rowe, 2006).  
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2.6 Roles of rosette formation in causing malaria-related anaemia 
 Interestingly, rosette formation has been proposed to drive massive destruction 
of non-parasitized erythrocytes, resulting in severe anaemia. A recent study had 
demonstrated transfer of haemozoin-generated lipid peroxidation end products from P. 
falciparum-infected erythrocytes to uninfected erythrocytes via rosette formation 
(Uyoga et al., 2012), which results in these modified uninfected erythrocytes being 
phagocytised and destroyed (Gallo et al., 2012; Uyoga et al., 2012). These haemozoin-
derived products have been shown to reduce an erythrocyte’s membrane deformability, 
which increases its risk of being cleared off circulation (Shorokhod et al., 2007). 
 
It is crucial once again to highlight the fact that these postulated roles for 
rosetting in falciparum malaria remain as hypotheses, and they are neither convincingly 
validated nor confidently ruled out by research studies thus far. Therefore, there is a 
possibility that rosetting event does not play any significant role in pathogenesis of 
malaria. Instead, it is just an intrinsic biological ability of the parasites that poses no 
significant advantage or disadvantage to their survival. Thus, it is important to conduct 
in-depth investigations to find out the significance of rosetting event in pathogenesis of 
malaria. 
 
2.7 A role played by rosetting in vivax malaria? 
In general, the roles of rosetting in vivax malaria are assumed by many to be the 
same as in falciparum malaria. As described previously, the major postulated role of 
rosetting in falciparum malaria is assisting development of vasculature occlusion. 
However, P. vivax shows rosette formation but does not cause cerebral malaria or other 
forms of severe malaria as often as P. falciparum (Anstey et al., 2009). Besides, P. 
vivax does not show significant deep vascular sequestration in the host. Nevertheless, P. 
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vivax has been proven to preferably accumulate in certain organs such as the lungs 
(Anstey et al., 2007; Jayavanth & Bock, 2007; Anstey et al., 2009). In addition, 
cytoadhesion of P. vivax happens, albeit less extensively than P. falciparum (Carvalho 
et al., 2010). Even so, enhancing vasculature occlusion may not be the major role of 
vivax malaria rosetting phenomenon. 
 
In vivax malaria, rosette formation may impede phagocytosis, which serves as an 
immuno-evasion mechanism of the parasite. Meanwhile, severe anaemia, splenic 
haematoma and splenic rupture are some of the complications reported in vivax malaria 
(Anstey et al., 2009). As P. vivax shows lesser degree of sequestration, rosetting alone 
may lead to erythrocyte pooling in spleen, which ultimately leads to mass destruction of 
uninfected erythrocytes by spleen filtration, resulting in severe anaemia. It has been 
demonstrated that both the infected and uninfected erythrocytes of vivax malaria 
patients show increased fragility, along with the increased deformability experienced by 
the infected erythrocytes (Handayani et al., 2009). The aggregates (rosettes) of such 
“fragile” erythrocytes under high shear force during splenic filtration may increase the 
probability of haemolysis. Anaemia will trigger erythropoietic machinery of the host, 
which results in increased rate of reticulocyte (non-matured erythrocytes) release into 
the bloodstream to support the haematological function of the host. This may be one of 
the survival strategies of P. vivax since it invades preferably, if not exclusively into the 
reticulocytes (Hegner, 1938; Kitchen, 1938; Russell et al., 2011). Nevertheless, 
dynamics of splenic function and vivax malaria has yet to be characterized, as with the 
rosetting properties of P. vivax. 
 
Similar to P. falciparum, rosetting is believed to assist merozoite reinvasion of P. 
vivax. Upon rupture of schizont, the merozoites have to search for suitable host 
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erythrocytes to invade and ensure survival. Rosette formation may provide convenience 
for these merozoites in the search for new host erythrocytes. Nevertheless, for this 
hypothesis to be applicable in vivax malaria setting, the participating uninfected 
erythrocytes in rosetting complex should predominantly consist of reticulocytes, the 
exclusive invasion target of P. vivax. Similar to postulated roles of P. falciparum 
rosetting, more in-depth studies are needed to validate these hypothetical roles of 
rosetting in P. vivax. 
 
2.8 Mechanisms of rosette formation in P. falciparum model: the receptors 
The mechanisms behind the formation of rosettes in malaria are yet to be well-
characterized. Nevertheless, many scientists support the hypothesis that Plasmodium 
spp. causes expression of certain proteins on the surface of the infected erythrocytes. 
These protein ligands (also known as “rosettins”) are complementary to the receptor 
proteins expressed on the uninfected erythrocytes (Sherman, 2005). As a result, the 
uninfected erythrocytes bind to the infected erythrocyte, forming rosettes. The concept 
is just like the classical “lock and key” hypothesis. 
 
Rosetting is not observed in all malaria-infected blood samples. Based on this 
early observation, scientists started looking for trends in rosetting occurrence, and a few 
interesting correlations have been discovered. There are studies showing that blood 
group A, AB and B yield higher prevalence of rosetting than blood group O (Carlson & 
Wahlgren, 1992; Udomsangpetch et al., 1993; Rowe et al., 1995; Rowe et al., 2007). 
The A and B trisaccharide antigens have been postulated to be the rosetting receptors on 
the uninfected erythrocytes (Rowe et al., 2007; Vigan-Womas et al., 2012; Rowe, 2013). 
Nevertheless, the relative tendency of rosette formation between blood group A, AB and 
B is not well characterized and information obtained from previous studies is rather 
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confusing. Blood group A has been proven by a few studies to show higher frequency 
of forming rosettes in falciparum malaria (Carlson & Wahlgren, 1992; Udomsangpetch 
et al., 1993). On the other hand, blood group B has been shown to have the highest 
frequency of forming rosettes when infected by certain strains of P. falciparum (Carlson 
& Wahlgren, 1992). Meanwhile, blood group AB showed the highest frequency of 
rosetting when infected with P. falciparum of Kenyan strain (Rowe et al., 1995). On the 
other hand, there are studies showing that blood group A forms stronger rosettes than 
blood group B does (Carlson et al., 1994). The prevalence of severe malaria symptoms 
is also significantly higher in patients with blood group A compared to other blood 
groups (Lell et al., 1999). This confusing situation may be due to the possibility that 
rosetting phenomenon is not solely affected by the ABO blood group, but other 
rheological aspects as well. The rosetting receptor requirements of different strains of P. 
falciparum may be different. Based on these accumulated data, it is likely that reliance 
on human blood group trisaccharides in rosette formation varies among different strains 
of P. falciparum. 
 
Interestingly, all the studies conducted so far have proven that blood group O 
shows the lowest tendency to form rosettes in falciparum malaria setting, and carries the 
lowest possibility to develop severe malaria symptoms (Migot-Nabias et al., 2000; 
Pathirana et al., 2005). This may be responsible for higher percentage of population 
with blood group O in malaria endemic areas of Africa (O’hUigin et al., 1997). The 
natural selective pressure exerted by malaria provides survival advantage to those 
carrying blood group O. Nevertheless, the situation where people with blood groups A, 
AB or B are wiped off the malaria hyper-endemic regions is not seen. This may be due 
to the compensatory factors carried by blood group O. For instance, people with blood 
group O have been shown to carry higher risk of contracting cholera (Harris et al., 
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2005). Besides the ABO blood group, a few pathological conditions of erythrocytes also 
confer certain extent of protection against severe malaria to the individuals having the 
particular genetic mutations. These include alpha-thalassemia, beta-thalassemia, sickle 
cell trait, G6PD-deficiency, Complement Receptor (CR) 1 deficiency, Southeast Asian 
Ovalocytosis and other haemoglobinopathies (Carlson et al., 1994; Pattanapanyasat et 
al., 1999, Wambua et al., 2006; Rowe et al., 2007). This may explain the higher 
prevalence of such genetic defects in malaria endemic regions such as Africa and 
Southeast Asia, and the presence of such phenotypes may “dilute” the impact exerted by 
human ABO blood groups on inherited protection against malaria. 
 
Besides the A and B trisaccharide antigens of human blood, a few protein 
candidates have been postulated as the receptors of rosetting ligands in falciparum 
malaria, which include the human complement receptor 1 (CR1/CD35), fatty acid 
translocase (CD36) and heparan sulphate (HS) (Leech et al., 1984, Handunnetti et al., 
1992; Wahlgren et al., 1992; Ringwald et al., 1993; Chotivanich et al., 2004; Vogt et al., 
2004; Leitgeb et al., 2011; Janes et al., 2011). Some of these candidates, with CR1 in 
particular, have been convincingly proven to play important role in rosette formation of 
P. falciparum. Anti-CR1 monoclonal antibody inhibits rosette formation of P. 
falciparum isolates (Rowe et al., 1997).  
 
Interestingly, sequestration has been observed to occur slightly earlier than 
rosetting in the erythrocytic life cycle of P. falciparum (Treutiger et al., 1998). For 
sequestration, CD36, HS, intercellular adhesive molecule 1 (ICAM 1), chondroitin 
sulphate A (CSA), E-selectin and thrombospondins (TSP) are postulated as the required 
receptors (Ockenhouse et al., 1992; Gardner et al., 1996; Treutiger et al., 1998; Vogt et 
al., 2004; Anstey et al., 2007). The sharing of receptors between rosette formation and 
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sequestration may allow the infected erythrocytes to form rosettes and attach to the 
endothelial cells of the capillary wall, subsequently resulting in vasculature occlusion as 
seen in severe falciparum malaria cases. 
 
Right before the initiation of this research project, a research group from 
Singapore conducted a preliminary study and discovered that human glycophorin C 
might be involved in rosetting event of P. falciparum (Prof. Dr. Peter Preiser, Nanyang 
Technological University, personal communication). Glycophorin C is a 
sialoglycoprotein with relatively huge extracellular domain (Smythe et al., 1994). The 
extracellular domain has various potential binding sites for different substances 
including viruses (Ohyama et al., 1993). Various antibodies against different sites of the 
extracellular domain of glycophorin C have been produced. For example, mouse anti-
human glycophorin C IgG clone BRIC 4 antibody acts on amino acid residue 2 to 21 
(Smythe et al., 1994). On the other hand, mouse anti-human glycophorin C IgG clone 
BRIC 10 antibody acts on the free amino group at the N-terminus of the domain (Dahr 
et al., 1989; Smythe et al., 1994). In view of the nature of glycophorin C’s structure 
(Figure 2.5), there is a need to validate the association of this sialoglycoprotein with 
rosetting phenomenon of P. falciparum and P. vivax, and subsequently elucidate the 
exact region on glycophorin C extracellular domain that is involved in rosetting event. 
 
Fascinatingly, glycophorin C has been proven as a key player in the erythrocytic 
invasion of P. falciparum (Chishti et al., 1996; Lobo et al., 2002; Mayer et al., 2006). 
Along with human band 3 protein (Castelino et al., 1981; Liu et al., 1990), glycophorin 
A (Ridgwell et al., 1983) and glycophorin B (Mayer et al., 2009; Li et al., 2012), 
glycophorin C is another receptor required by P. falciparum merozoites to invade the 
erythrocyte. Mutations on glycophorin C such as Gerbich negative phenotype and 
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Leach phenotype confer partial resistance against P. falciparum invasion (Chishti et al., 
1996; Maier et al., 2003). If glycophorin C were involved in rosette formation of P. 
falciparum, this sialoglycoprotein may be the link between the parasite’s rosetting 
phenomenon and invasion events. The relative importance of glycophorin C in P. 
vivax’s pathobiology is not well understood. Nevertheless, it would be interesting to 
find out the relationship between glycophorin C and the rosetting event of P. vivax. 
 
In view of the diverse rosetting receptor candidates found so far, the 
mechanisms and properties of rosettes formation by malaria parasites may be different 
among various strains of the same species. Such differences may be driven by 
geographical and host demographic factors as well. 
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Figure 2.5 Schematic diagram of glycophorin C structure, with the amino acid 
sequences of the extracellular domain shown in the box underneath the depicted 
structure. The amino acid residues encoded by exon 1, 2 and 3 of the gene, along with 
the targeting region of mouse anti-human glycophorin C IgG clone BRIC 4 and clone 
BRIC 10 antibodies were shown in the box as well. 
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2.9 Mechanisms of rosette formation in P. falciparum model: the ligands 
Unlike the receptors involved in rosette formation, the number of candidates 
suggested and confirmed as rosetting ligands is relatively low (Helmby et al., 1993; 
Rowe et al., 1997; Chen et al., 1998; Mayor et al., 2004; Horata et al., 2013). Most of 
the studies conducted so far have focused on PfEMP1 (Rowe et al., 1997; Chen et al., 
1998; Mayor et al., 2004; Horata et al., 2013). 
 
PfEMP1 is a group of trypsin-sensitive, variant surface antigens (VSA) encoded 
by var genes (Baruch et al., 1995). The haploid genome of P. falciparum erythrocytic 
stage contains around 60 var genes (Gardner et al., 2002). For any individual infected 
erythrocyte, only one variant of var protein is expressed. Through this antigenic 
variation strategy, the parasites can evade host’s immune responses. Surely, host’s 
immune responses will be elicited following recognition of these parasitic antigens 
expressed on the surface of infected erythrocytes. However, the antibodies raised 
against the PfEMP1 are mostly variant specific (Marsh & Howard, 1986; Newbold et al., 
1992). Therefore, the partial immunity arises from previous exposure to a particular 
strain of P. falciparum may confer protection against severe malaria during the second 
infection by only against the very same strain of parasite. Without doubt, such partial 
immunity will not protect the host from contracting falciparum malaria (Chen et al., 
2000). In addition, this partial immunity may be specific to only a particular parasite 
strain, resulting in very limited protection against the infection. Such strategy enables 
establishment of chronic P. falciparum infection (Kyes et al., 2007). 
 
The Duffy-binding-like-alpha (DBLα) domain of PfEMP1 (also known as 
PfEMP1- DBLα) is supported by many studies to be the rosetting ligand (Rowe et al., 
1997; Chen et al., 1998; Mayor et al., 2004; Mayor et al., 2009; Horata et al., 2009). 
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However, the PfEMP1- DBLα of different strains of P. falciparum shows varied 
binding affinity to different rosetting receptors, such as CR1 (Rowe et al., 1997; Mayor 
et al., 2009), heparan sulphate, and blood group A trisaccharide (Chen et al., 1998; 
Chen et al., 2000). This reflects the diverse nature of receptor-ligand interaction in 
rosetting event of P. falciparum. Today, PfEMP1 is still the focus of rosetting research 
in P. falciparum model, with particular attention on elucidating the specific region on 
PfEMP1 that serves as the rosetting ligand (Horata et al., 2009; Angeletti et al., 2012; 
Angeletti et al., 2013; Adams & Rowe, 2013). 
 
The “surface receptor-ligand” theory for rosette formation mechanism sounds 
simple and straight-forward. However, this surface receptor-ligand theory cannot 
explain the phenomenon of giant rosette formation where the uninfected erythrocytes 
are seen adhering to a rim of uninfected erythrocytes that are adhered to the infected 
erythrocyte (Udomsangpetch et al., 1995). Since the outer rims of erythrocytes do not 
get into contact with the surface of the infected erythrocyte, the ligands involved in 
rosette formation are not located exclusively on the surface of the infected erythrocytes. 
The proteins responsible for rosetting may be secreted out of the infected erythrocytes 
to the surrounding before adhering to the nearest surface of any erythrocytes. 
 
2.10 Current knowledge about rosetting event of P. vivax 
In contrast to the comprehensive studies on rosetting studies of P. falciparum, 
the rosetting event of P. vivax has not been deeply investigated. Hence, knowledge on 
the basic properties of rosettes formed by P. vivax-infected erythrocytes is limited. 
 
Based on the limited amount of investigations conducted (Udomsangpetch et al., 
1995; Chotivanich et al., 1998), it has been shown that rosettes formed by P. vivax are 
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sensitive to a variety of reagents such as heparin and enzyme trypsin. Besides, the 
rosetting event of P. vivax is dependent of divalent ions such as calcium (Ca2+) and 
magnesium (Mg2+). In addition, a few studies showed that the rosetting event of P. 
vivax is independent of the human ABO blood groups. The relationship between 
rosetting event and vivax malaria severity is not intensively studied. Recently, P. vivax 
rosetting has been correlated to anaemia in vivax malaria patients from Manaus, Brazil 
(Marín-Menéndez et al., 2013). Besides, receptors involved in rosetting event of P. 
vivax are yet to be explored. Similarly, ligands involved in P. vivax rosetting event 
remain as a mystery. Obviously P. vivax has been neglected for a long time in malaria 
research. 
 
2.11 Difficulties in implying rosetting knowledge of P. falciparum onto P. vivax 
As mentioned earlier, different species of Plasmodium may behave differently in 
cellular biology and pathobiology. It would be difficult, if not impossible to completely 
derive knowledge gained from studies on a particular species to other species of the 
same genus. Certain differences are so distinct that hypotheses on biological properties 
of a species based on extrapolation of findings on another species are hardly possible. 
For instance, receptor-ligand interaction of rosetting event in P. falciparum is well 
studied, with the light of focus shone towards the PfEMP1 protein. However, PfEMP1 
has no orthologs in P. vivax, raising concern that the rosetting receptors deduced from 
studies on P. falciparum may not be relevant to P. vivax’s settings. In view of the lack 
of understandings on the rosetting properties of P. vivax, coupled with the fact that P. 
vivax are different from P. falciparum in many aspects, there is a need to specifically 
investigate the biological properties of rosette formed by P. vivax isolates, and 
subsequently decipher the roles played by this phenomenon in pathogenesis. 
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2.12 Methods available for conducting rosetting-related experiments 
To investigate rosetting phenomenon of malaria parasites, a good technique of 
visualizing and characterizing the rosettes is required. This technique must be accurate, 
convenient to prepare, simple and workable under various conditions, including field 
settings. There are a few methods available from previous studies conducted on this 
topic. Different study groups have applied different techniques for their studies. Each 
method poses distinctive strength and weaknesses, which are elaborated as follow. 
 
Giemsa-stained thin blood smear was used to visualize and characterize rosettes 
of P. falciparum-infected blood samples (Le Scanf et al., 2008). This technique is 
simple, easy to prepare and cheap. However, it is almost impossible to differentiate 
between a real rosettes and a mere clump of erythrocytes under thin smear examination. 
Application of this technique on rosetting characterization raises doubts on its relative 
accuracy and practicality. 
 
The second method used for rosetting study is fluorescent microscopy using wet 
mount preparation. This is the most frequently used method for rosetting studies 
(Udomsangpetch et al., 1989; Carlson et al., 1990b; Chen et al., 1998; Chotivanich et 
al., 1998; Clough et al., 1998; Treutiger et al., 1998; Deans & Rowe, 2006). This 
technique applies fluorescent dyes such as acridine orange or ethidium bromide to stain 
the parasite’s nucleic acids. Thus, rosettes are visualized. This method is accurate and 
produces good visual evidence for rosetting phenomenon. However, fluorescence 
microscope may not be available in every laboratory setting, especially laboratories in 
rural areas, where malaria is more likely to be endemic. Besides, fluorescent dyes must 
be stored and handled properly to ensure long shelf life and optimal performance. 
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The third method involves unstained wet mount examination using light 
microscope (Udomsangpetch et al., 1992). This is also a convenient and cheap 
technique. However, a good phase contrast microscope, coupled with an experienced 
microscopist is required to optimally differentiate between malaria parasites and 
artifacts under unstained condition. 
 
The fourth technique involves application of wet mount preparation from 
malaria culture suspension of 5% haematocrit concentration, stained supravitally with 
10% Giemsa (Chotivanich et al., 1998). This method visualizes the parasites as seen 
from thin blood smear under microscopic examination, enabling rosetting investigation 
to be conducted with simple equipment. Nevertheless, when this method was tried prior 
to the initiation of this research project, it was found that the formula stated conferred a 
crowded cell population under the wet mount, which hindered optimal visualization and 
characterization of the rosettes. Besides, crenation happened rapidly after the 
preparation (less than 5 minutes post-preparation), causing characterization of rosettes 
difficult to be implemented with this method. As the wet mount is placed on the 
microscope stage and shone by the light for examination, heat generated from the light 
source causes water evaporation of the wet mount medium, making the originally 
isotonic extracellular milieu hypertonic to the cells, and hence the cellular crenation. 
Therefore, the ratio of cell density to water content of the wet mount suspension must 
be adjusted to resist fast development of crenation. Obviously, an improved method is 
needed for optimal visualization and characterization of the rosettes.  
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2.13 Additional haematological aspect that deserves attention 
Since research study on rosetting phenomenon is considered as a form of 
haematological investigation, it is crucial and beneficial for the project to 
simultaneously look into other haematological aspects of the recruited samples. One 
particular haematological aspect that deserves attention in this project is the reticulocyte 
profile of the sample. As mentioned earlier, reticulocyte is the immature erythrocyte that 
serves as the exclusive invasion target for P. vivax. Reticulocytes are differentiated from 
the matured erythrocytes (normocytes) by having reticulated matters (remnants of 
ribosomes and RNA) within the cytoplasm (Brecher, 1949; Rowan, 1991). Besides, the 
size of a reticulocyte is slightly larger than that of a normocyte, and the shape of a 
reticulocyte tends to be slightly irregular instead of the biconcave morphology seen in 
normocytes (Brecher, 1949; Rowan, 1991; Riley et al., 2001) (Figure 2.6). In order to 
validate the hypothesis that rosette formation enhances merozoites reinvasion, 
reticulocyte characterization is undoubtedly an essential part of this study. 
 
There are a few methods available for reticulocyte characterization (NCCLS, 
2004). The gold standard technique for reticulocyte profiling is microscopic 
examination on thin smear prepared from blood suspension stained supravitally with 
reticulocyte stains (Rowan, 1991; Riley et al., 2001; NCCLS, 2004). The commonly 
used reticulocyte stains include new methylene blue (NMB) and brilliant cresyl blue 
(Brecher, 1949; Koepke & Koepke, 1986). This technique works by visualizing the 
reticulated matters within the cytoplasm of the reticulocytes, thus enabling 
differentiation of reticulocytes from other erythrocytes. This old, gold standard 
technique is cheap and easy to prepare. However, this method is time consuming with 
inconsistent performance as significant variations were observed in reticulocyte staining 
and visualization by the reticulocyte stains produced by different manufacturers, as well 
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as inter-batch variation by the very same company (Rowan, 1991). Furthermore, this 
technique is inaccurate when applied on samples infected with haemoprotozoa such as 
Plasmodium spp. and Babesia spp. This is due to the fact that reticulocyte stains cannot 
optimally stain the parasites, causing difficult differentiation between the 
haemoprotozoa and reticulocyte’s reticulated matters. 
 
Other methods are automated techniques, which include automated blood cell 
counter and flow cytometry (Rowan, 1991; NCCLS, 2004). Nevertheless, the principles 
behind this technique are the same as the gold standard technique, which involve 
staining and visualization of the reticulated matters within the reticulocytes. The 
automated technique is fast but expensive. Besides, it requires stable power supply in 
the laboratory setting (Ali et al., 2010). This particular requirement poses problems to 
many laboratories in rural areas and developing countries whose power supply is 
usually unstable. More importantly, this sophisticated technique is also inaccurate when 
applied on blood samples infected with haemoprotozoa (Rowan, 1991; Riley et al., 
2001). Obviously, a much better technique is needed for optimal characterization of 
reticulocytes on malaria-infected blood samples. 
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Figure 2.6 Smear prepared from blood stained supravitally with new methylene 
blue (NMB). The reticulocytes are characterized by the presence of reticulated matters 
within the cytoplasm, slightly larger size, and slightly irregular shape. (Diagram source: 
Website of Faculté de médecine, Université de Rennes 1: https://facmed.univ-
r e n n e s 1 . f r / r e sp e d / h e m a t o / C C / C D / c d / an / d o s s i e r s / r e t i e / s h e e t se . h t m ) . 
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2.14 Problem statement 
Rosette formation is definitely not a new topic in malaria research. Many studies 
have been conducted to understand this biological phenomenon. Nevertheless, there is 
an obvious imbalance in attention allocation to medically important malaria parasites 
when it comes to malaria rosetting research. Although P. vivax is the second most 
prevalent cause of global malaria burden, attention given to this species is far lesser that 
that received by P. falciparum. Therefore, more studies are required to fill the rosetting 
knowledge gap between P. falciparum and P. vivax. 
 
Throughout the course of this research project, the following questions were 
raised: does P. vivax form rosettes as frequently as P. falciparum? Is there any 
correlation between rosetting event and clinical settings of the patient, such as 
parasitaemia and reticulocyte reading of the patient? How similar, and of course, how 
different are rosetting events of P. vivax and P. falciparum? Which type of blood 
samples should be used for this experiment? What are the requirements, such as the 
receptors needed by P. vivax to form rosettes? What are the roles (if any) played by 
rosetting event in P. vivax infection? And to investigate these questions, which is the 
most suitable technique for this research project?  
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METHODOLOGY 
 Due to the nature and requirements of this research project, fieldworks were 
conducted and based in Shoklo Malaria Research Unit (SMRU), Thailand, using 
malaria samples from the Thai-Myanmar border. Part of the work for technique 
development was carried out in the Singapore Immunology Network (SIgN) of Agency 
for Science, Technology and Research (A*STAR), Singapore. Data analysis and 
interpretation was conducted in the University of Malaya, Malaysia. 
 
3.1 Technique development for reticulocyte visualization 
This work was intended to develop a field technique that is suitable for 
haematological investigations, as stated in objective 1.5.1. 
 
3.1.1 Blood sample collection and processing 
Blood samples were collected from infected and uninfected donors after 
obtaining written informed consent following ethical guidelines in the approved 
protocols (OXTREC 027-025, University of Oxford, Centre for Clinical Vaccinology 
and Tropical Medicine, UK and MUTM 2008-215 from Medical Ethic Committee of 
Faculty of Tropical Medicine, Mahidol University). Blood samples were collected into 
BD Vacutainer® with lithium heparin anticoagulant. All samples were processed 
freshly upon collection or stored at 4°C for not more than 24 hours prior to processing. 
 
3.1.2 Preliminary study: NMB smear versus NMB wet mount 
A preliminary study using only uninfected blood samples were conducted to 
compare reticulocyte counting between the traditional NMB smearing technique and the 
NMB wet mount technique. Good correlation between the two methods does not 
ultimately indicate the good agreement between the methods. Therefore the Bland-
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Altman plot was used to analyze correlation and the degree of agreement (pattern of 
bias) between two methods.  
 
From this preliminary study, the reticulocyte counts of both methods were 
comparable to each other (Figure 3.1). As a result, subsequent comparison of NMB wet 
mount technique and the Giemsa wet mount technique was feasible.  
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Figure 3.1 Bland-Altman plot showing comparison of reticulocyte counting 
between the gold standard NMB smearing technique and NMB wet mount 
technique. Slope = -0.1850 to 0.2184 (95% CI); slope not significantly deviated from 
zero (P = 0.8531). Both methods are comparable to each other. 
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3.1.3 NMB smear (gold standard method) 
Blood samples were supravitally stained with NMB (Sigma-Aldrich®) stock 
solution in a 1:1 volume ratio. After incubation over a period of 10 minutes at room 
temperature, a thin blood smear was prepared from the stained blood suspension. The 
blood film was air-dried prior to examination under light microscope (Olympus IX53®). 
 
3.1.4 NMB wet mount method 
For this technique, 50 µl of each blood sample was stained supravitally with 50 
µl NMB stock solution (1:1volume ratio) for 10 minutes at room temperature. The 
stained blood cell suspension was centrifuged and the pellet was resuspended at 3% 
haematocrit with plain McCoy’s 5A medium (Gibco®) [could be substituted with RPMI 
1640 medium (Gibco®)]. Subsequently, 7.5 µl of the stained suspension was dropped 
onto a glass slide and then covered with a 22 x 32 mm (0.17 mm thickness) glass cover 
slip.  
 
3.1.5 Giemsa wet mount method 
Another 50 µl of each unstained blood sample was stained supravitally with 2.5 
µl of a filtered solution of Giemsa (Sigma-Aldrich®) (final staining concentration = 5%) 
for 15 minutes at room temperature, followed by gentle mixing. Then, a wet mount was 
prepared as described above for NMB wet mount technique.  
 
3.1.6 Reticulocyte counting 
All specimens, especially the wet mounts were examined immediately with oil 
immersion light microscopy. Reticulocyte percentage number was determined by 
counting the number of reticulocytes per 1000 erythrocytes (ICSH, 1998). 
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3.2 Rosetting visualization and characterization 
This work was conducted to characterize the rosetting properties of P. vivax 
(objective 1.5.2), as well as to compare the rosetting properties between P. vivax and P. 
falciparum (objective 1.5.3). 
  
3.2.1 Experiments on fresh malaria samples 
For the collected malaria-positive blood samples, ABO blood group of each 
sample was determined via standard haemagglutination with TransClone® Anti-A and 
Anti-B antibodies (Bio-Rad, California, USA). Thick and thin blood smears were 
prepared from each blood sample to determine species of malaria parasites involved, 
parasitaemia and the predominant erythrocytic stage of the parasite. 
 
Malaria-infected blood samples with at least 70% of the parasite population 
being “ring” stages were matured in vitro in Mc Coy’s 5A medium enriched with 20% 
homologous serum at 5% haematocrit concentration, as described previously (Russell et 
al., 2012). These samples were examined at different time intervals that represented ring, 
early trophozoite, late trophozoite and schizont stages. Visualization and 
characterization of rosettes were conducted using the Giemsa wet mount method 
described above. The wet mounts were examined immediately using light microscope 
under oil immersion. Rosetting rate and rosetting prevalence were determined. 
 
3.2.2 Experiments on cryopreserved malaria samples 
Vivax malaria blood samples with at least 70% of parasite population in ring 
form were cryopreserved using the glycerolyte method as described previously 
(Christofinis & Miller, 1983; Borlon et al., 2012). Prior to cryopreservation, vivax 
malaria samples with parasitaemia lower than 0.1% were subjected to 75% Percoll 
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density gradient centrifugation to concentrate the parasitized erythrocytes. The 
cryopreserved samples were then thawed using the sodium chloride method (Blomqvist, 
2008). Subsequently, the thawed samples were matured in vitro and rosetting assay was 
conducted as described above. Rosetting rate of each cryopreserved isolate and the 
rosetting prevalence of cryopreserved isolates were determined. 
 
3.3 Rosetting erythrocyte preference study 
This study was conducted to investigate the potential roles of rosetting in vivax 
malaria, as stated in objective 1.5.4. Blood samples infected with either P. vivax or P. 
falciparum were matured in vitro until at least 60% of the parasite population reached 
schizogony. Subsequently, 100 µl of each culture suspension was used as a control 
where its rosetting rate was determined. Erythrocytes infected with mature-stage 
parasites were concentrated using magnetic activated cell sorting column (MACSTM) 
(Miltenyi Biotec). The concentrated infected erythrocytes (volume = x) were 
subsequently mixed with 0.5x volume of uninfected packed normocytes and 0.5x 
volume of uninfected packed reticulocytes. The red cell mixture was then suspended in 
enriched McCoy’s 5A medium as described above. 
 
Preformed rosettes were dissociated mechanically via two minutes of vigorous 
vortexing. In a preliminary study, it was observed that the formed rosettes dissociated 
when they were subjected to vigorous vortexing (around 1500 rpm) for as brief as one 
minute. After that, the freed infected erythrocytes resumed rosetting within seconds, and 
the rosetting rate recovered slowly back to the original value within five minutes (Table 
3.1). 
 
45 
 
The vortexed cellular suspension was then incubated at 37°C for 30 minutes 
prior to rosetting assay. Subsequently, the types of erythrocyte subsets involved in 
rosette formation of P. vivax and P. falciparum were determined. 
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Table 3.1 Recovery of rosetting rate of P. falciparum and P. vivax isolates after vortexing (preliminary study). Samples were collected from 
various Thai-Myanmar border refugee camps in Tak Province, Thailand.  
 
Malaria 
Isolates 
Original 
Roseting  
rate 
(%) 
Rosetting  
rate 1s  
post-vortex 
(%) 
Rosetting  
rate 1min 
post-vortex 
(%) 
Rosetting 
rate 2 min 
post-vortex 
(%) 
Rosetting 
rate 3 min 
post-vortex 
(%) 
Rosetting 
rate 4 min 
post-vortex 
(%) 
Rosetting 
rate 5 min 
post-vortex 
(%) 
Rosetting  
rate 6 min 
post-vortex 
(%) 
Rosetting  
rate 7 min 
post-vortex 
(%) 
P. vivax 
BPD 093 
 
27.5 
 
1.0 
 
5.0 
 
14.5 
 
23.5 
 
27.0 
 
27.5 
 
27.5 
 
27.5 
PID 403733 26.0 2.0 6.0 11.5 19.5 26.0 26.0 26.0 26.0 
PID 403897 27.5 2.5 7.0 15.0 21.0 27.0 27.0 27.5 27.5 
PID 403891 29.5 0.5 8.0 13.0 24.0 29.0 30.0 29.0 29.5 
PID 403926 23.0 1.5 4.5 9.5 17.5 23.0 23.0 23.0 23.0 
PID 401198 15.0 0.5 5.0 9.0 13.0 14.0 15.0 15.0 15.0 
BPD 097 26.0 1.0 15.0 20.0 24.0 24.0 26.0 26.0 26.0 
VHX 521 51.0 0.5 19.0 35.0 44.0 50.5 51.0 51.0 51.0 
BPD 095 
 
0 0 0 0 0 0 0 0 0 
P. falciparum 
MMA 2163 
 
7.5 
 
0 
 
1.5 
 
5.0 
 
5.5 
 
7.0 
 
7.5 
 
7.5 
 
7.5 
MRC 0153 0 0 0 0 0 0 0 0 0 
TH 004069 10.0 1.0 2.0 4.5 7.5 10.0 10.0 10.0 10.0 
PID 101059 20.5 1.0 2.5 5.5 12.5 18.0 20.5 20.5 20.5 
PID 104150 12.5 0.5 3.0 6.5 9.0 12.5 12.5 12.5 12.5 
NHP 1437 6.0 0.5 2.0 4.0 5.0 5.5 6.5 6.0 6.0 
MMA 3052 10.0 1.0 2.0 3.0 7.0 10.0 10.0 10.0 10.0 
NHP 1440 9.0 1.5 2.5 5.0 7.0 8.0 9.0 9.0 9.0 
NHP 1439 
 
12.0 2.0 4.5 6.0 9.5 12.0 12.0 12.0 12.0 
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3.4 Elucidating rosetting receptors of P. vivax and P. falciparum 
These experiments were conducted to characterize the rosetting properties of P. vivax 
(objective 1.5.2), as well as to compare the rosetting properties between P. vivax and P. 
falciparum (objective 1.5.3).  
 
3.4.1 Anti-human glycophorin antibodies 
 For this experiment, three types of antibodies were chosen, namely, mouse anti-
human glycophorin A (CD235a) IgG (Abcam, Cambridge, UK), mouse anti-human 
glycophorin C  (CD236R) IgG clone BRIC 4 (Thermo Scientific Pierce, USA), and 
mouse anti-human CD236R IgG clone BRIC 10 (Abcam, Cambridge, UK). Preliminary 
trials clearly showed that the intact anti-glycophorin C and A antibodies caused 
considerable haemagglutination. Therefore it was necessary to use Fab fragments of 
anti-CD236R and anti-CD235a antibodies. Antibody Fab fragments of these antibodies 
were prepared using the Pierce® Fab Micro Preparation Kit-Resin Kit (Thermo 
Scientific Pierce, USA). 
 
The antibody Fab fragment preparation was to ensure specific binding of the 
antibodies to target sites due to the proximity of the selected targeting sites to each other, 
as well as to other proteins, which may be potential binding sites for any biological 
event. By preparing this step, the possibility of rosetting inhibition due to steric 
hindrance caused by the large complete immunoglobulin structure could be ruled out. 
Besides, this preparation can prevent haemagglutination, which was seen in the 
preliminary studies when these antibodies were applied directly as complete 
immunoglobulin. 
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 When the in vitro matured culture suspension showed at least 70% of the 
parasite population being late erythrocytic stages, four aliquots of the culture suspension 
were prepared. The aliquots were vortexed vigorously for two minutes to mechanically 
dissociate any pre-formed rosettes.  
 
After that, each aliquot was mixed with one type of the antibody Fab fragments 
prepared earlier (final concentration = 1000 µg/ml), and one remaining antibody-free 
aliquot served as the negative control. The aliquots were mixed well by vortexing, and 
incubated for 30 minutes at 37°C. Subsequently, rosetting assay was conducted on each 
aliquot as described above. 
 
3.4.2 Anti-human complement receptor 1 (CR1/ CD35) antibody 
 Steps similar to those used in experiment with mouse anti-human glycophorin 
antibody Fab fragments were used in this experiment. As this antibody did not cause 
haemagglutination in preliminary trials, antibody fab fragment preparation was 
exempted. Mouse anti-human CD35 IgG (BD PharmigenTM) with final antibody 
concentration of 20 µg/ml (within the concentration range of effective P. falciparum 
rosetting inhibition described in previous study) was used (Rowe et al., 1997). 
Untreated aliquot of culture suspension served as the negative control. Indeed, this 
experiment itself also served as a positive control to the experiment with mouse anti-
human glycophorin antibody Fab fragments. 
 
3.4.3 Haematopoietic cell culture and CD236R knockdown; Rosetting inhibition 
Cryopreserved human umbilical cord blood mononuclear cells (HUMC) were 
expanded using a method described previously (Giarratana et al., 2011) with few 
modifications. Briefly, the CD34+ haematopoietic progenitors were isolated by 
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immuno-magnetic selection using CD34 MicroBead kit (MiltenyiBiotec). The CD34+ 
cells were harvested during 3 weeks in IMDM Glutamax (Gibco®) supplemented with 
330 g/ml of human holotransferin (Sigma®), 10 g/ml recombinant human insulin 
(SAFC Biosciences®), 2 IU/ml heparin (Sigma®) and 5% AB serum. Between day 0 
and 7, the following additional supplementation were incorporated: 10-6 M of 
hydrocortisone (StemCell TechnologiesTM), 100 ng/ml of SCF (Peprotech®), 5ng/mL of 
IL-3 (Peprotech®) and 3 UI/ml of Epo (StemCell TechnologiesTM), between day 7 and 
day 11, 100 ng/mL of SCF and 3 UI/mL of Epo, and after day 11 only Epo was added. 
 
One day after the immuno-magnetic sorting, the CD34+ cells were transduced 
(MOI of 5) with shRNA lentitvector MISSION™, shRNA Target Set NM_002101 
(Glycophorin C [CD236R]) (Sigma®) in the presence of 8 g/ml of Polybrene (Sigma®). 
Fifteen days after the transduction, GFP positive and negative cells were sorted using 
Influx BD flow cytometer (BD biosciences). The day after, GFP positive and negative 
fraction were incubated with P. vivax late stages isolated by magnetic sorting as 
described previously (Malleret et al., 2011). The level of CD236R expression in each 
subset was measured by flow cytometry using anti-human CD236R clone BRIC4 
(Thermo scientific) antibody as primary staining and anti-mouse e660 (eBioscience) as 
secondary staining. The cells were acquired on LSRII flow cytometer (BD Biosciences) 
and analysed with FlowJo software (Tree Star). 
 
3.5 Anti-malarial drug challenge assay 
 This study was conducted to investigate the potential roles of rosetting in vivax 
malaria, as stated in objective 1.5.4. Seven anti-malarial compounds were used in the 
study, namely artesunate, chloroquine, mefloquine, amodiaquine, lumefantrine, quinine 
and methylene blue. Drug well plate with different compound concentrations of each 
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drug were prepared using serial dilution technique. For serial dilution, as the drugs show 
different hydrophilicity, different solvents were used to dissolve and dilute the drug 
compounds. Double distilled water was used for serial dilution of chloroquine, 
amodiaquine and methylene blue, 70% ethanol was used for serial dilution of artesunate, 
mefloquine, and quinine, whereas a combination of Triton X-100, Linoleic acid and 
absolute ethanol in 1: 1: 1 ratio was used for serial dilution of lumefantrine. 
When the in vitro matured culture suspension showed at least 70% of the 
parasite population being late erythrocytic stages, the culture suspension was transferred 
to the prepared drug plate and incubated at 37°C for 2 hours prior to rosetting assay. 
Non-treated culture suspension of each recruited malaria isolate was used as the control. 
 
3.6 Human white blood cell (WBC) challenge assay 
 This study was conducted to investigate the potential roles of rosetting in vivax 
malaria, as stated in objective 1.5.4. Malaria-infected blood samples collected in heparin 
collecting tubes were centrifuged at 1800 rpm for 5 minutes. After that, buffy coat 
(WBC rich region) of the blood sample was carefully removed and collected, 
subsequently filtered through a CF11 cellulose powder column. The filtered packed 
erythrocytes were then divided into two; one part used for in vitro cultivation at 3% 
haematocrit suspension (control group), whereas the other part was mixed with the 
collected buffy coat prior to in vitro maturation with similar condition as mentioned 
previously. Rosetting assay was conducted when at least 70% of the parasite population 
reached late stages. 
 
3.7 Statistical analysis and interpretation 
Rosetting rate is defined as the percentage of infected erythrocytes that form 
rosettes in 200 recruited infected erythrocytes. Giant rosette is defined as a rosetting 
51 
 
complex with the participation of at least 10 uninfected erythrocytes (Udomsangpetch et 
al., 1989; Udomsangpetch et al., 1995). Percentage of giant rosette formed was 
calculated. The percentage of recruited isolates that showed rosetting phenomenon was 
expressed as rosetting prevalence. 
 
As most of the data were not normally distributed, non-parametric analysis such 
as Mann-Whitney U, Kruskal-Wallis (more than two groups) and Friedman test 
(repeated measures) were utilised. In the latter two tests Dunn’s post hoc analysis was 
used. All statistical analysis used Prism 5 for Windows (version 5.01), Software 
MackievTM. Correlation analysis was conducted to study relationship between rosetting 
rate and parameters of interest. Bland-Altman analysis was applied to study degree of 
agreement between two techniques under comparison (Bland & Altman, 1995). The 
experiments covered in this research project, with the number of samples used are 
summarized in Figure 3.2. 
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Figure 3.2 Flow chart showing the experiments conducted in this research project 
with the number of samples used. 
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RESULTS 
4.1 Technique development for reticulocyte visualization 
 For comparison between NMB wet mount and Giemsa wet mount techniques, a 
total of 103 malaria-infected blood samples from the Thai-Myanmar border were used. 
The samples consisted of 69 isolates of P. vivax, 32 isolates of P. falciparum, 1 isolate 
of P. malariae, and 1 isolate of mixed infection of P. vivax and P. falciparum. The 
highest reticulocyte count based on the average value of the two studied methods was 
6.45% and the lowest being 0.07%. 
 
 The precipitated reticulated matters within the cytoplasm of the reticulocytes 
were clearly visualized by either the NMB (Figure 4.1A) or the Giemsa (Figure 4.1B) 
wet mount method. Giemsa produced a lighter staining pattern by specifically staining 
only the reticulated matters of the reticulocytes. On the other hand, NMB produced a 
non-specific purplish coloration (background staining) in all erythrocytes regardless of 
their infection status or haematological stage (Figures 4.1A & 4.2A). Nevertheless, both 
wet mount methods enabled clear differentiation between reticulated matters of 
reticulocytes and parasitic matters (Figure 4.2A & B). Besides, the irregular shape and 
larger size of reticulocyte relative to normocyte were clearly shown using thes 
techniques. 
 
 The mean reticulocyte count in P. vivax isolates (1.3% ± 2SD 1.05) was not 
significantly different from that in P. falciparum isolates (1.57% ± 2SD 0.88) (p = 0.19). 
Both the NMB wet mount and Giemsa wet mount methods were significantly correlated 
(Pearson R = 0.97; 95% CI 0.8799 to 0.9934; r2 = 0.96; p < 0.0001) (Figure 4.3). Bland-
Altman analysis indicated a good agreement between these two methods (95% limit of 
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agreement 20.30% and 0.54%) without significant pattern of bias (Bias = 0.05 SD of 
Bias 0.2) (Figure 4.4).  
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Figure 4.1 Erythrocytes under wet mount prepared from suspension stained 
supravitally with NMB (A) and Giemsa (B) respectively. The reticulocytes (indicated 
by red arrows) are erythrocytes with darkly stained reticulated matters within the 
cytoplasm. Chemical structure of respective staining molecules is indicated at the upper 
right corner of each picture. 
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Figure 4.2 P. vivax-infected erythrocytes under wet mount prepared from 
suspension stained supravitally with NMB (A) and Giemsa (B) respectively. 
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Figure 4.3 Linear regression of reticulocyte readings between NMB and 
Giemsa wet mount methods. 
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Figure 4.4 Bland-Altman comparison of reticulocyte readings between NMB 
wet mount technique and Giemsa wet mount technique. 
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4.2 Technique development for rosetting visualization  
 The Giemsa wet mount technique, which was modified from a previous study 
(Chotivanich et al., 1998) and developed for the reticulocyte characterization, was 
successfully applied for rosette visualisation as well. The malaria parasites were stained 
clearly, and the rosettes were visualised (Figure 4.5) by using only simple equipment 
and materials such as Giemsa stain, glass slides, glass cover slips and compound light 
microscope. By using the Giemsa wet mount, true rosettes can be differentiated easily 
from a mere overlap or clump of erythrocytes due to the fluidic surrounding of wet 
mount setting.  
 
 
 
 
60 
 
 
Figure 4.5 P. vivax-infected erythrocytes that form rosettes (A & B) and that do 
not form rosettes (C & D) from Giemsa wet mount preparation. 
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4.3 Rosetting characterization 
4.3.1 Rosetting development of P. vivax 
  Rosette formation of P. vivax increased with the parasite erythrocytic 
maturation (Figure 4.6). In this study, no early stages (ring forms) were found to be 
involved in rosette formation. Rosette formation of P. vivax was noted 24 hours post 
cultivation, represented by early trophozoite stages. The rosetting rate increased 
markedly between early the trophozoite stage and the late trophozoite stage. After 30 
hours the rosetting development continued, albeit with much lower rate, until the 
parasite reached schizogony at hour 44 (Figure 4.6). Such rosetting development trend 
is similar to that reported previously for P. falciparum (Figure 4.6) (Udomsangpetch et 
al., 1989). Beside the asexual stages, gametocytes of P. vivax were also found to be 
involved in rosette formation (Figure 4.6). Involvement of gametocyte-infected 
erythrocytes in rosette formation was found in P. falciparum isolates as well (Figure 
4.6). 
 
4.3.2 Giant rosette characterization 
Giant rosettes were found occasionally. Around 10% of the rosettes (223 out of 
2233 rosettes) in P. vivax isolates were giant rosettes (Figure 4.7A). On the other hand, 
only around 0.5% of the rosettes (4 out of 759 rosettes) found in P. falciparum isolates 
were giant rosettes (Figure 4.7B).  
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Figure 4.6 Plot showing rosetting development of rosette-forming P. vivax 
isolates along the erythrocytic maturation. Rosettes formed by different stages of P. 
vivax and P. falciparum are shown beneath the plot. 
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Figure 4.7 Giant rosettes formed by erythrocytes infected with P. vivax (A) and 
P. falciparum (B). 
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4.3.3 Rosetting prevalence of P. vivax 
 At the beginning of this research project, considering the high cost of conducting 
overseas fieldwork research, only cryopreserved P. vivax isolates from the Thai-
Myanmar border were used. However, after conducting several experiments and data 
interpretation, it was found that the cryopreserved vivax malaria isolates differed from 
the fresh vivax malaria isolates in rosetting capability. For the cryopreserved vivax 
malaria isolates, 19 out the 45 isolates examined showed rosetting phenomenon, with 
rosetting prevalence of 42.22%. The highest rosetting rate recorded from this batch of 
cryopreserved samples was 30.00% with the lowest being 0.20% (only 1 rosette found 
after examining 500 infected erythrocytes). The rosetting prevalence obtained from 
these cryopreserved samples was much lower than that reported in a previous study 
using fresh vivax malaria isolates from Thailand (rosetting prevalence recorded = 
71.00%) (Udomsangpetch et al., 1995). Therefore, a decision was made to repeat the 
experiment with the fresh malaria isolates from the same area. 
 
 When the experiment was repeated with fresh vivax malaria isolates, the 
rosetting prevalence recorded was as high as 91.49% (43 out of 47), with the highest 
rosetting rate recorded as 61.00% and the lowest being 2.00%. When the rosetting data 
between the fresh vivax malaria isolates and the cryopreserved vivax malaria isolates 
were compared using the Mann-Whitney U test, significant difference between the two 
groups was noted; P (two-tailed) < 0.0001 (Figure 4.8). The rosetting capability of fresh 
P. vivax isolates was significantly higher than that of the cryopreserved isolates. These 
results indicate that cryopreservation affects rosetting capability of the vivax malaria 
isolates. This finding is different from that of fresh and cryopreserved P. falciparum 
isolates reported earlier (Kyriacou et al., 2007). 
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Figure 4.8 Plot showing significant difference in rosetting rates between fresh 
and cryopreserved P. vivax isolates, with the mean values of respective groups. 
Mann-Whitney U test was performed, P (two-tailed) < 0.0001. 
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4.3.4 Rosetting prevalence of P. falciparum 
The rosetting prevalence of fresh P. falciparum isolates of the Thai-Myanmar 
border was studied as well. The rosetting prevalence recorded was 79.49%; with the 
highest rosetting rate being 28.00% and the lowest being 3.00%. Interestingly, when the 
median rosetting rates between fresh isolates of P. vivax and P. falciparum were 
compared using Mann-Whitney U test, the value of the fresh P. vivax isolates (24.5%) 
was significantly higher than that of P. falciparum (9.0%), P (two-tailed) < 0.05 (Figure 
4.9). 
 
4.3.5 Correlation study of rosetting phenomenon and different clinical 
parameters 
 For both P. vivax and P. falciparum isolates, no significant correlation was 
found between rosetting rate and parasitaemia of the isolates (Figure 4.10). The 
parasitaemia range for P. vivax and P. falciparum was 0.01 – 1.70% and 0.10 – 11.00%, 
respectively. Similarly, no significant relationship was found between rosetting rate and 
peripheral reticulocyte counting of the isolates in both P. vivax and P. falciparum 
isolates (Figure 4.11). Besides, no significant correlation was found between rosetting 
rate and ABO blood groups of vivax and falciparum malaria patients from this region 
(Figure 4.12). 
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Figure 4.9 Comparison of rosetting rate between P. vivax and P. falciparum 
isolates from the Thai-Myanmar border. For P. vivax isolates, 95% CI (18.68 to 
29.45) and for P. falciparum isolates, 95% CI (6.46 to 13.50); Mann-Whitney U test 
was conducted, there is significant difference between the medians of rosetting rate 
between isolates of P. vivax and P. falciparum; P (two tailed) < 0.05. 
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Figure 4.10 Correlation of rosetting rate and parasitaemia in vivax malaria and 
falciparum malaria isolates from the Thai-Myanmar border. Spearman correlation 
test was performed. For P. vivax isolates, Spearman r = -0.1013; 95% CI (-0.39 to 0.20); 
P (two-tailed) = 0.4983 i.e. no significant correlation found. For P. falciparum isolates, 
Spearman r = -0.0626; 95% CI (-0.38 to 0.27; P (two tailed) = 0.7051. In both species, 
no significant correlation was found. 
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Figure 4.11 Correlation of rosetting rate and peripheral reticulocyte count in 
vivax malaria and falciparum malaria cases from the Thai-Myanmar border. 
Spearman correlation test was performed. For P. vivax isolates, Spearman r = -0.1013; 
95% CI (-0.39 to 0.20); P (two-tailed) = 0.4983. For P. falciparum isolates, Spearman r 
= -0.0626; 95% CI (-0.38 to 0.27; P (two tailed) = 0.7051. In both species, no 
significant correlation was found. 
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Figure 4.12 Plot showing rosetting rate of P. vivax and P. falciparum isolates in 
different human ABO blood groups. Kruskal-Wallis with Dunn’s multiple 
comparison test was conducted. For P. vivax isolates (P = 0.2672) and for P. falciparum 
(P = 0.2033), there was no significant difference in rosetting rate between different 
human ABO blood groups. 
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4.4 Rosetting erythrocyte preference study 
 A total of 11 falciparum and 8 vivax malaria isolates were used in this study. For 
both P. falciparum and P. vivax incubated in a reticulocyte-enriched environment, only 
few rosettes were noted involve reticulocyte (Figure 4.13 A-D). A total of 562 and 391 
rosettes were examined in P. vivax and P. falciparum isolates, respectively. Only 
around 10% of the rosettes examined for both species of malaria parasites had 
reticulocyte involvement even under a reticulocyte-rich milieu (Figure 4.14). In contrast, 
all rosettes found from P. vivax isolates had normocyte involvement, whereas 388 out of 
the 391 rosettes (99.23%) in P. falciparum isolates showed normocyte involvement.  
 
 When the rosetting rates of each isolate under reticulocyte-enriched environment 
and non-reticulocyte-enriched setting (control) were compared using Wilcoxon signed-
rank test, no significant difference was found for the P. vivax isolates. On the other hand, 
rosetting rates of P. falciparum isolates showed significant reduction when they were 
subjected to reticulocyte-enriched setting (P (one-tailed) < 0.01) (Figure 4.15). 
Although reticulocytes were seen occasionally in few P. vivax rosetting complexes from 
the reticulocyte-enriched settings, the formation of rosettes almost exclusively involved 
normocytes despite the even chance to encounter reticulocytes. As there may be 
concerns regarding the difference between cord blood reticulocytes and peripheral 
reticulocytes, the reticulocyte enrichment experiment was repeated by using three fresh 
isolates of P. vivax and reticulocytes isolated from two adult donors. No significant 
difference was found between the cord blood and peripheral-derived reticulocytes in 
their lack of involvement in P. vivax rosetting. (Figure 4.16). Instead, rosettes of P. 
falciparum and P. vivax consist predominantly of normocytes, as shown in the 
experiments when both reticulocytes and normocytes were provided equally for the 
infected erythrocytes to form rosettes. 
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Figure 4.13 Rosettes captured during the rosetting erythrocyte subset preference 
study in P. vivax isolates (A & B) and P. falciparum isolates (C & D). Rosettes are 
indicated by red arrows whereas reticulocytes are indicated by the black arrows. 
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Figure 4.14 Plot showing the percentage of rosettes with reticulocyte 
involvement in each recruited isolate under reticulocyte-enriched setting. Median 
value of each group is shown in the plot. 
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Figure 4.15 Plot showing differences in rosetting rate of P. vivax and P. 
falciparum isolates under environment with less than 1% reticulocytes and 
environment with approximately 50% reticulocytes. Differences in rosetting rate of 
P. vivax and P. falciparum isolates in environment with less than 1% reticulocytes and 
environment with approximately 50% reticulocytes (achieved by concentrating host 
reticulocytes on a 75% percoll gradient). Lines connect paired observations. Altering 
the reticulocyte concentration had little effect on P.vivax rosette formation; however the 
number of normocytes attached to the P.vivax IRBC was notably reduced in the 
treatment of enriched reticulocytes. Interestingly an increase in the available 
reticulocytes reduced the ability of P. falciparum to rosette (P < 0.01).  
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Figure 4.16 Type of erythrocytes involved in rosetting using different sources of 
blood (peripheral adult blood or cord blood). Concentrated late stage P. vivax were 
exposed to >50% reticulocytes collected from adult peripheral blood (A-C). In rare 
cases type II and III reticulocytes were found to clump with each other (red asterisk) 
and not with the parasites (similar to that of cord blood reticulocytes). Note also that 
only biconcave normocytes (no reticular Giemsa staining pattern) rosette with the 
parasites (yellow arrow). 58 and 183 rosettes were observed from the adult and cord 
blood respectively. The frequency of these rosettes being associated with at least one 
reticulocyte was scored (D). Reticulocytes were rarely involved with rosetting. 
Additionally, there was no significant association (chi-square with Yates’s correction) 
between the types of erythrocyte involvement and the sources of reticulocyte used.  
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4.5 Elucidating rosetting receptors of P. vivax and P. falciparum 
4.5.1 Mouse anti-human glycophorin antibodies (Fab fragments) 
 The rosetting phenomenon of P. vivax and P. falciparum isolates were 
significantly inhibited by Fab fragments of mouse anti-human glycophorin C (CD236R) 
IgG clone BRIC 4 (Figure 4.17B). Based on the Friedman analysis with Dunn’s 
multiple comparison test, rosetting of P. vivax was significantly reduced by 27%; P < 
0.05. Meanwhile, rosetting of P. falciparum was inhibited by at least 50%; P < 0.05. 
Interestingly, rosetting events of both P. vivax and P. falciparum were not affected by 
the Fab fragments of mouse anti-human CD236R IgG clone BRIC 10, which acts 
specifically on the amino terminus of glycophorin C (Figure 4.17A). Besides, rosetting 
of both species of malaria parasites was not affected by the Fab fragments of mouse 
anti-human glycophorin A (CD235a) IgG (Figure 4.18). 
 
4.5.2 Mouse anti-human complement receptor 1 (CR1/ CD35) antibody 
 Based on paired t-test, significant rosetting inhibition was seen in P. falciparum 
isolates; P (two-tailed) < 0.0001 in the presence of anti-human CD35 antibody. This 
result is parallel to findings from a previous study (Rowe et al., 1997). However, 
rosetting of P. vivax isolates was not affected by the mouse anti-human CD35 antibody; 
P (two-tailed) = 0.2722. The mouse anti-human CD35 antibody significantly reduced 
rosetting of P. falciparum, but not in the case of P. vivax (Figure 4.19). 
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Figure 4.17 Schematic diagram of the target sites of anti-glycophorin C antibody 
clone BRIC 10 and anti-glycophorin C antibody clone BRIC 4 on human 
glycophorin C. The target site of enzyme trypsin on this sialoglycoprotein is shown 
as well (A). Plot showing the extent of rosetting inhibition exerted by the Fab 
fragments of the antibodies used on P. vivax and P. falciparum isolates studied (B). 
One way ANOVA with Dunn’s multiple comparison test was conducted to study the 
difference between the groups. The Fab fragment of mouse anti-human glycophorin C 
antibody clone BRIC 4 produced significant reduction in rosetting of P. falciparum 
isolates (P < 0.0001) and P. vivax isolates (P < 0.0001). 
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Figure 4.18 Comparison of rosetting rates between the control and cells 
incubated with Fab fragments of mouse anti-human glycophorin A antibody from 
the recruited P. falciparum and P. vivax isolates. Mann-Whitney U test was 
conducted. There is no significant difference between the control group and the “anti-
glycophorin A” group in P. vivax (P = 0.6687) and P. falciparum (P = 0.5692) isolates 
studied. 
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Figure 4.19 Plot showing the extent of rosetting inhibition by mouse anti human 
CD35 antibody.  Paired t test was conducted. For P. falciparum isolates, P (two tailed) 
< 0.0001; t = 5.808; df = 16; R = 0.8236. For P. vivax isolates, P (two tailed) = 0.2722; t 
= 1.147; df = 13; R = 0.3031. The antibody significantly reduced rosetting rate of P. 
falciparum isolates. 
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4.5.3 Haematopoietic cell culture and CD236R knock down; Rosetting inhibition. 
Although the above antibody Fab-mediated inhibition assays provide useful 
clues to the identity of the host rosetting receptor, such an approach is limited by 
potential off-target effects (such as steric hindrance or changes to membrane rigidity) 
(Bei & Duraisingh, 2012). To limit these unwanted off-target effects, a transgenic 
method to knockdown the expression of CD236R was employed to produce normocytes 
that are mostly deficient in this receptor (Figure 4.20A). Phenotyping of GFP positive 
and GFP negative cells (according to BRIC4 region recognition (Figure 4.17A)) showed 
a knockdown of 81.5% ± 2.5% in CD236R expression (Figure 4.20B). It should be 
noted that the method employed in this experiment was different from the one used 
recently in a previous study to knock down the expression of Glycophorin A (where 
piromycin and neomycin rather than GFP was used for the selection) (Bei et al., 2010; 
Bei & Duraisingh, 2012). Nevertheless, both methods have the same knock down 
efficiency. It is important to note that the erythrocytes generated from the CD236R 
knockdown had a normal phenotype in terms of seven other characteristic erythrocytic 
receptors (Figure 4.21). 
 
Initially this work needed to be conducted in Singapore, thus the experiment had 
to rely on cryopreserved isolates of P.vivax. Of the three P.vivax isolates used only one 
showed very high levels of rosetting (>50%). Despite this limitation, differences in 
rosetting between the control normocytes (CD236R positive) and CD236R knockdown 
normocytes were immediately evident. After examination of 200 fields (1000x 
magnification) and counting 50 P. vivax-infected erythrocytes per treatment, only 4 of 
50 were rosetting with CD236R knockdown erythrocytes compared to 27 out of 50 in 
the control (chi-square = 22.6, d.f  = 1, P < 0.0001 [chi-square with Yates’s correction]). 
Since usage of cryopreserved samples may raise confounding effects to the rosetting 
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results (Figure 4.8), the experiment was repeated in the Thai-Myanmar border by using 
three fresh isolates. It was found that the CD236R knockdown erythrocytes significantly 
reduced the formation of rosettes (P < 0.001) (Figure 4.20D). It is important to 
understand that although the cells were sorted on GFP, this protein has about 26 hours 
half-life in mammalian cells. Therefore, the signal gradually diminishes as the 
erythrocyte matures (Corish & Tyler-Smith, 1999). Consequently the normoblasts 
(Heilmeyer stage 0) and early reticulocytes (Heilmeyer stage I, II and III) have bright 
signals. Mature reticulocytes (Heilmeyer stage IV) and normocytes have little or no 
discernable signal (Figure 4.20C). An unintended benefit of this age related GFP signal 
output was that in the four rosettes observed in the CD236R knockdown, no rosette was 
associated with GFP positive cells (reticulocytes), thus further supporting earlier data on 
P.vivax rosette normocytic preference. 
 
82 
 
 
Figure 4.20 Transgenic approach to investigate the role of CD236R in P. vivax 
rosetting. Experimental design of P. vivax rosetting assay with cultured erythrocytes 
(cRBCs) generated from CD34+ haematopoietic stem cells (HSCs). The stable 
knockdown of CD236R (Glycophorin C) is obtained using Sigma® lentivector with 
GFP and short hairpin RNA (shRNA) against CD236R expression. The 2 subsets of 
cells: CD236R knockdown and CD236R+ cells were separated by flow cytometry using 
GFP expression one day before performing the rosetting assay with P. vivax schizont-
infected erythrocytes that were isolated by magnetic sorting (A). Flow cytometry 
histograms showing CD236R expression in GFP positive cells (CD236R knockdown 
cells in green line) and GFP negative (CD236R+ cells in black line) and unstained cells 
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in grey line (B). Erythrocyte infected with P. vivax schizont forms rosette with CD236R 
knockdown (CD236R KD) and non-CD236R knockdown (CD236+) erythrocytes using 
bright field (BF), Hoechst and GFP detection (C). Rosetting rates of erythrocytes 
infected with P. vivax schizonts in the presence of CD236R knockdown cultured RBCs 
(cRBCs) and CD236+ cRBCs respectively (D). A significant difference in rosetting 
rates between the two types of cRBCs was found. 
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Figure 4.21 Flow cytometry histograms showing phenotypes of erythroblasts 
generated from cord blood CD34+ haematopoietic stem cells. Plots showing surface 
expression of erythrocytic markers in GFP positive cells (CD236R knock down cells in 
green line), GFP negative (CD236R+ cells in blue line) and unstained cells in grey line. 
This set of plots highlights that the CD236R knockdown cells have a normal phenotype 
in terms of seven other characteristic erythrocytic receptors (CD35, CD44, CD234, 
CD71, CD235a, CD238 and CD240DCE). 
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4.6 Anti-malarial drug challenge assay 
 Within the concentration range tested, after two hours of incubation, rosetting 
rates of both P. falciparum and P. vivax increased with the elevation of drug 
concentrations. For P. falciparum isolates, there were significant differences between 
the rosetting rate of control and that of chloroquine (from 192.97 ng/ml onwards) 
(Figure 4.22A), mefloquine (from17.53 ng/ml onwards) (Figure 4.22C), amodiaquine 
(from 9.41 ng/ml onwards) (Figure 4.22E), artesunate (from 2.38 ng/ml onwards) 
(Figure 4.22G), quinine (from 1262.64 ng/ml onwards) (Figure 4.22I), lumefantrine 
(from 28.75 ng/ml onwards) (Figure 4.22K), and methylene blue (from 1.25 ng/ml 
onwards) groups (Figure 4.22M); P < 0.05. For P. vivax isolates tested, there were 
significant differences between the rosetting rate of control and chloroquine (from 
385.94 ng/ml onwards) (Figure 4.22B), mefloquine (from 70.13 ng/ml onwards) (Figure 
4.22D), amodiaquine (from 9.41 ng/ml onwards) (Figure 4.22F), artesunate (from 4.75 
ng/ml onwards) (Figure 4.18H), quinine (from 157.83 ng/ml onwards) (Figure 4.22J), 
lumefantrine (from 3.59 ng/ml onwards) (Figure 4.22L), and methylene blue (from 
0.625 ng/ml onwards) groups (Figure 4.22N); P< 0.05.  Prior to this experiment, a 
preliminary test with the anti-malarial drugs was performed on uninfected erythrocytes 
from three uninfected donors (with blood group A, B and O respectively). Clumping 
and crenation of the erythrocytes were not detected in any of the drug concentrations 
used. Similarly, during the study, crenated cells and clumping of uninfected 
erythrocytes were not found. This observation implies that the range of drug 
concentrations used in this study did not affect the osmolarity of the suspension and 
induce formation of artifacts that may affect the results of the study.  
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Figure 4.22 Plots showing changes of rosetting rate upon brief exposure to 
different drug concentrations. 
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Figure 4.22, continued Plots showing changes of rosetting rate upon exposure 
to different drug concentrations. One way ANOVA with Dunn’s multiple comparison 
test was performed to compare the rosetting rates after exposure to various drug 
concentrations with those of the control. Areas under * are the ranges of drug 
concentrations yielding rosetting rates that were significantly higher than those of the 
drug-free control (P<0.05). 
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4.7 Human white blood cell (WBC) challenge assay 
 For all the recruited P. vivax and P. falciparum isolates, parallel comparison of 
rosetting rate between the WBC-supplied and WBC-free cultivation systems was done. 
For each isolate, rosettes found in both cultivation settings showed similar size range 
(participating uninfected erythrocytes ranged from 2 to 25 cells) (Figure 4.23 A & B). 
No significant difference was found in comparison of giant rosette formation between 
the batch matured with WBCs and the batch matured without WBCs (Figure 4.24). 
Therefore, the size of rosettes was not influenced by the presence of WBCs. Besides, 
autoagglutination of infected erythrocytes was not found in all isolates tested. In 
addition, infected erythrocytes were rarely found to be attached to the WBCs.  
 
From the recruited P. vivax isolates, the rosetting rates obtained from culture 
suspension with WBCs were significantly higher than those from WBC-free culture 
suspension; P (two tailed) <0.0001 (Figure 4.25). A similar trend was found on P. 
falciparum isolates as well; P (two tailed) <0.05 (P = 0.0212) (Figure 4.25). 
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Figure 4.23 Rosettes formed by a P. vivax isolate matured ex vivo without WBCs 
(A), and in the presence of WBCs (red arrow) (B) respectively.  
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Figure 4.24 Plots showing giant rosettes found in recruited malaria isolates 
under WBC-free condition and condition with WBCs. Paired t-test was conducted. 
For P. vivax isolates tested, P (two tailed) = 0.6752; t = 0.4287; df = 13; R = 0.1181. For 
P. falciparum isolates recruited, P (two tailed) = 0.4226; t = 1.000; df = 2; R = 0.5773. 
No significant difference in the relative abundance of giant rosette formation between 
WBC-supplied setting and WBC-free setting for both P. vivax and P. falciparum 
isolates recruited. 
91 
 
Without WBC With WBC
0
20
40
60
80
100
***
R
o
se
tti
n
g 
(%
)
Without WBC With WBC
0
10
20
30
40
50 *
R
o
se
tti
n
g 
(%
)
P. vivax
P. falciparum
 
Figure 4.25 Plots showing rosetting rate comparison of malaria isolates that were 
subjected to in vitro maturation with WBCs and without WBCs. Paired t-test was 
conducted to study the comparison.  For P. vivax isolates, P (two tailed) < 0.0001; t= 
8.799; df = 13; R= 0.925. For P. falciparum isolates, P (two tailed) = 0.0212 (P < 0.05); 
t= 6.755; df= 2; R= 0.978. Rosetting rate was significantly increased with the presence 
of WBCs in both P. vivax and P. falciparum isolates. 
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DISCUSSION 
5.1 Technique development for reticulocyte and rosette visualization 
Approximately half the world’s population reside in malaria endemic regions 
(Breman et al., 2004), and most of these areas suffer from severe limitations of health 
infrastructure. Therefore, clinical haematology in these regions is largely dependent 
upon differential stains and microscopy rather than flow cytometry or other automated 
methods used in developed countries. The most widely practiced method for 
reticulocyte counting involves smearing supravitally stained blood on slides prior to 
microscopic examination, rather than using the wet mounting method developed in this 
study. Unfortunately, reticulocyte assessment of NMB-stained smears is complicated by 
the presence of artifactual ribosomal matter resulting from current or past (due to 
splenic pitting) malaria parasite infection. Furthermore, erythrocytes containing the 
early ‘ring’ forms of Plasmodium spp. and degraded dead malaria parasites can easily 
be mistaken for reticulocytes on NMB smears. 
 
These issues are not entirely solved with the use of flow cytometry methods. 
Although DNA-specific stains enable exclusion of parasitized erythrocytes from the 
analysis (Nunez, 2001), reticulocytes infected with malaria parasites (especially P. vivax 
merozoites post invasion) are also ‘gated out’ from the total reticulocyte population. 
Consequently, reticulocyte quantification of both methods may not reflect the actual 
haematological condition of malaria patients. Due to this problem, even though a field-
based flow cytometer (BD AccuriTM C6) was available, the flow cytometry comparison 
with this newly developed Giemsa-wet mount method was not done, since the presence 
of malaria parasites would significantly confound the results.  
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Application of wet mounting technique (NMB and Giemsa) kept malaria 
parasites alive during the examination period. The active movement of live parasites 
was easily differentiated from the static reticular matter of reticulocytes. Dead parasites 
were distinguished from reticulocytes based on the darker staining pattern of the latter. 
In most cases, parasitic and host reticular matters possess discernible differences in 
thickness, opacity, and refractive indices; light travelling through these entities is 
subjected to different degrees of optical interference. Such optical effects are further 
magnified by the liquid medium of wet mount, which has refractive index higher than 
that of air. However, such optical phenomena are not available on the dry smear. Hence, 
the optical differentiation of live parasites, dead parasites, and reticulocytes is best 
contrasted in wet mounting method. The preference for wet mount staining concurs with 
earlier work that used wet mounts of supravitally stained blood from vivax malaria 
patients to confirm the preference of P. vivax for reticulocyte invasion (Vryonis, 1939). 
While the results from the present research project show that wet mount preparation 
from both staining methods (NMB and Giemsa) provided almost identical reticulocyte 
counts, the Giemsa method is marginally preferable to NMB due to its low cost and 
longer shelf life. However, Giemsa requires longer staining time (15 minutes) than 
NMB (10 minutes). Based on this study, a 5% Giemsa staining formulation is 
recommended for the staining procedure. 
 
Reticulocyte quantification using the Giemsa wet mount method has some 
limitations. A bright halo effect called spherical aberration may arise (Figure 5.1). This 
effect is especially pronounced during the usage of cover slips with thickness that is 
incompatible to the objectives of light microscope (Gibson & Lanni, 1992; Wan et al., 
2000). Use of immersion oil with incompatible refractive index can also induce this 
optical effect (Gibson & Lanni, 1992; Wan et al., 2000). Nevertheless, this problem can 
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be alleviated by using an appropriate glass cover slip (0.17 mm thickness). Nikon 
immersion oil type A with refractive index of 1.515 at 23°C allowed optimal 
visualization with minimal spherical aberration. Another potential problem of the 
Giemsa-wet mount method is the cell movement that can impede cell counting. 
However, this problem can be solved by using the appropriate volume of suspension 
with glass cover slips of appropriate size in preparing the wet mounts. In this research 
project, it was found that 7.5 µl cell suspension of 5% haematocrit with cover slip of 22 
x 32 mm (0.17 mm thickness) produced an even cell distribution with minimal cell 
movement. In addition, the wet mounts should not be examined on a slanted bench top. 
The wet mounts should be checked immediately after preparation, and counting must be 
performed as soon as possible. As the heat of the microscope light source accelerates 
water loss, cell crenation will be noted if the wet mount is examined for longer than 20 
minutes. Riming the outside of the coverslip with Vaseline and storage in a cool dark 
place will allow for examination at a later time (6 hours after preparation). 
 
The Giemsa-wet mount technique developed here was indeed a technique 
modified from a method described in a previous study on rosetting characterization 
(Chotivanich et al., 1998). The modified protocol applied in this research project 
enables optimal visualization of malaria parasites with minimal usage of laboratory 
resources (Lee et al., 2013b). Besides, the viable parasites can be kept alive while the 
cellular morphology of host erythrocytes and parasites are visualized and characterized. 
In addition, this improved formula enables longer investigation duration of the wet 
mount on microscope. Using 5% instead of 10% Giemsa staining formulation applied in 
previous study (Chotivanich et al., 1998), cellular crenation rate was much lower when 
the wet mount was observed under microscope. 
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Figure 5.1 P. vivax-infected and uninfected erythrocytes under wet mount 
prepared from suspension stained supravitally with Giemsa. Spherical aberration, 
which is a “halo” rim effect around each erythrocyte, is clearly demonstrated in this 
picture. 
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5.2 Rosetting characterization of P. vivax 
 Similar to P. falciparum, rosetting phenomenon is found only after P. vivax 
matures into the early trophozoite stage. As the parasites require time to synthesize and 
transport various proteins onto the surface of the infected erythrocytes, it is not 
surprising to see such rosetting trend. Indeed, it has been shown that the rosetting ligand 
of P. falciparum, PfEMP1, starts appearing on the surface of the infected erythrocytes 
when the parasite matures into late ring form, which concurs with the emergence of 
cytoadherence properties of P. falciparum (Gardner et al., 1996; Kyes et al., 2000; 
Kriek at al., 2003). Nevertheless, as mentioned earlier, the rosetting ligand of P. vivax 
has yet to be discovered.  
 
 Prior to this research project, gametocytes were believed to be unable to form 
rosettes (Lowe et al., 1998). Rosette formation of gametocytes was deemed illogical in 
the transmission cycle of malaria since gametocytes should be available freely in the 
peripheral circulation instead of posessing cytoadherence properties. Such belief was 
considered as a supporting point for the hypothetical role of rosetting in enhancing the 
asexual merozoite reinvasion (Lowe et al., 1998). In this research project, it has been 
shown that gametocytes of P. vivax and P. falciparum can be involved in rosette 
formation. Before going deeper into the discussion on this topic, it should be 
emphasized here that rosette formation and deep vein sequestration are two separate 
biological phenomena of malaria parasites, as highlighted in previous study (Adams et 
al., 2014). Therefore, they should not be regarded as mutually dependant events. 
Developing gametocytes of P. falciparum (stage I to IV), but not matured gametocytes 
(stage V), have been found to sequester in bone marrows (Smalley et al., 1981; Rogers 
et al., 2000). Since mature gametocyte-infected erythrocytes must be available in 
peripheral circulation in order to sustain the transmission cycle via Anopheles mosquito 
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bites, rosette formation may serve as a physical shield, protecting the infected 
erythrocytes from host’s immuno-recognition and phagocytic destruction by the 
phagocytes. Nevertheless, this remains as a postulation and should be further verified 
with more experiments. 
 
 Giant rosettes were found more frequently in P. vivax than P. falciparum 
isolates. Such finding may arise from the difference in relative stability of parasite-
derived rosetting ligands in anchoring onto the host erythrocyte membrane. The 
rosetting ligand of P. falciparum is securely anchored on the surface of uninfected 
erythrocyte membrane. Only uninfected erythrocytes that come into direct contact with 
the infected erythrocyte will involve in rosette formation. On the other hand, the 
rosetting ligands of P. vivax may be more loosely anchored on the surface of infected 
erythrocytes. As uninfected erythrocytes come into contact with the infected erythrocyte, 
the loosely bound ligands may be transferred onto the surface of uninfected erythrocytes, 
enabling another rim of uninfected erythrocytes to bind with the uninfected erythrocytes 
that are already involved in rosetting complex. The principle is analogically similar to 
the transfer of pollens from flower to bees. As the rosetting ligands are not tightly 
anchored on the erythrocyte membrane, they will not stay anchored on the surface of 
these uninfected erythrocytes for a very long time within circulation. Hence, the 
scenario where uninfected erythrocytes also form “rosette-like clumping” in P. vivax 
isolates was not seen.  
 
 Previously, a few studies reported that cryopreservation does not affect the 
rosetting capability of P. falciparum isolates (Kinyanjui et al., 2004; Kyriacou et al., 
2007; Ribacke et al., 2013), and rosetting-related experiments were conducted with 
cryopreserved isolates (Vigan-Womas et al., 2008). These previous studies indicate that 
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the structural integrity of P. falciparum rosetting ligands is well preserved during the 
cryopreservation and thawing processes. On the other hand, the effect of 
cryopreservation on P. vivax rosetting was not studied. From this research project, it 
was found that the rosetting capability of cryopreserved P. vivax isolates was much 
lower than that of fresh P. vivax isolates of the same geographical origin. The integrity 
of certain surface proteins may not be well preserved during the cryopreservation and 
thawing processes. The ligands responsible for rosette formation of P. vivax may be one 
of such proteins. Consequently, the rosetting capability of cryopreserved P. vivax 
isolates is lowered. This discovery highlights another biological difference between P. 
vivax and P. falciparum. 
 
 Based on this study, rosetting prevalence of P. vivax is higher than that of P. 
falciparum, indicating that rosetting phenomenon is common among P. vivax. Such 
finding is contradictory to previous belief that P. vivax was one of the species with low 
rosetting capability (Sherman, 2005). However, the rosetting ability of P. vivax may 
vary from one geographical strain to another. Another point worth mentioning is the 
relatively higher rosetting rates shown by individual P. vivax isolates (2.00% to 61.00%; 
median = 24.5%) as compared to P. falciparum isolates (3.00% to 28.00%; median = 
9.0%). Rosetting and endothelial cytoadhesion are the contributing forces towards deep 
vascular sequestration, which is believed to assist the matured parasites in immune-
evasion (Berendt et al., 1994; Amante et al., 2010). Although P. vivax has been shown 
to preferably accumulate in certain organs such as lungs (Anstey et al., 2007; Jayavanth 
& Bock, 2007; Anstey et al., 2009), the extent of its cytoadhesion is much lower than 
that of P. falciparum (Carvalho et al., 2010). As a result, deep vascular sequestration in 
vivax malaria may not happen as frequently or extensively as that seen in falciparum 
malaria. Thus, the matured trophozoites of P. vivax need alternative strategies to escape 
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host’s immune responses. Rosette formation may act as one of those immune-evasion 
strategies for the matured stages. This may be a reason that the rosetting rate median of 
P. vivax isolates is higher than that of P. falciparum.   
 
 Unlike a few previous studies from African countries and one recent report from 
Brazil that had found significant correlation between rosetting rate and clinical 
parameters such as patient’s parasitaemia as well as different forms of severe malaria 
(Rowe et al., 1995; Rowe et al., 2002; Le Scanf et al., 2008; Doumbo et al., 2009; 
Marín-Menéndez et al., 2013), no significant correlation was found between rosetting 
rate and parasitaemia, or similarly, and peripheral reticulocyte count from this research 
project. Such discrepancy may reflect the virulence differences among parasites of 
different strains or geographical origins. More importantly, it is difficult to conduct a 
meaningful correlation study between rosetting rate and the clinical parameters 
prevalent at sample collection. As these clinical data are obtained in “snap-shot” mode, 
the actual, meaningful correlation between rosetting and clinical presentations may not 
be reflected from the collected data. Besides, haematological data such as peripheral 
reticulocyte count, haematocrit and platelet reading can be influenced by various 
confounding factors such as underlying disorders and nutritional problems, especially in 
places like Thai-Myanmar border (Stoltzfus, 2001; Kemmer et al., 2003; Boel et al., 
2010), where sampling for this research project was conducted. In addition, disease 
severity on a patient depends on how prompt the patient attend to doctor for treatment. 
With various confounding factors, such correlation study is difficult to be implemented. 
Indeed, a previous study using clinical samples from Papua New Guinea reported no 
significant correlation between falciparum malaria severity and rosetting phenomenon 
(al-Yaman et al., 1995). 
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5.3 Elucidating rosetting receptors of P. vivax and P. falciparum 
 An important finding from this project is the lack of significant correlation 
between rosetting and human ABO blood groups among both P. vivax and P. 
falciparum isolates. The lack of significant correlation between rosetting rate and ABO 
blood groups in P. vivax isolates was similar to that reported previously (Chotivanich et 
al., 1998). This finding further confirms that human ABO blood group antigens do not 
play significant roles in rosetting of P. vivax. The lack of association between human 
ABO blood groups and CR1 with P. vivax rosetting should not be surprising as the 
ligand responsible for this interaction in P. falciparum (PfEMP1) is absent from P. 
vivax. On the other hand, human ABO blood groups have been incriminated as one of 
the coreceptors for P. falciparum rosetting (Udomsangpetch et al., 1993; Rowe et al., 
1995; Barragen et al., 2000; Rowe et al., 2007; Tekeste & Petros, 2010; Vigan-Womas 
et al., 2012). The contradictory finding from this research project may be due to several 
reasons. 
 
Firstly, there are a few rosetting coreceptors for P. falciparum. The P. 
falciparum strains of the region under study may have evolved to prefer other antigen 
candidates over the human A or B blood group antigens as the rosetting coreceptors. 
This is analogically similar to the rosetting phenomenon of P. falciparum VarO strain, 
which is CR1-independent but ABO-dependent (Vigan-Womas et al., 2012). The ABO 
blood group polymorphisms of the human population may be another contributing 
factor to the different finding yielded from this project. For instance, there are different 
subgroups for blood group A alone (Poskitt & Fortwengler, 1974), and some of these 
subgroups have been demonstrated to show varied affinity to the DBL1a1-CIDR1c 
double domain of PfEMP1, the rosetting ligand of P. falciparum (Vigan-Womas et al., 
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2012). Nevertheless, genetic characterization of the human population is beyond the 
scope covered by this research project.  
 
 In this research project, rosetting phenomenon of P. vivax was found to be 
independent of CR1. Once again, this finding shows that the biological properties of P. 
vivax are not entirely the same as P. falciparum. The efforts to shortlist novel receptors 
mediating P. vivax rosetting were aided by findings from preliminary studies, in which 
P. falciparum rosetting is mediated by CD236R (Glycophorin C) in a PfEMP1-
independent manner (Prof. Dr. Peter Preiser, personal communication). In this research 
project, by specifically blocking the BRIC 4 region (amino acid residues 2 – 21) of 
CD236R, rosette formation of P. falciparum and P. vivax was significantly inhibited. As 
most of the BRIC 4 region is located in segment one of CD236R (Figure 4.15A), it is 
unlikely that the Gerbich and Yus phenotypes (which cause major deletions at exon 2 
and 3) will have any effect on rosetting capability. It is interesting to note that enzyme 
treatment of erythrocytes with trypsin completely removes two of the extracellular 
domains of CD236R (segment 1 and 2) (Figure 4.15A), resulting in complete 
abrogation of rosetting in P. vivax (Russell et al., 2011). 
 
 To further confirm the importance of CD236R as a key player in P. vivax 
rosetting, expression of CD236R on normocytes was blocked using knock down 
experiment with haematopoietic stem cells. Rosetting assays using these CD236R-
knock down erythrocytes clearly showed a significant reduction of rosetting phenomena 
in P. vivax as compared to normocytes (from the same culture) that expressed CD236R. 
One problem with the idea that CD236R is important to rosetting, is that presentation of 
this receptor is decreasing during reticulocyte maturation to normocyte, albeit still 
highly expressed in both erythrocyte subsets (Malleret et al., 2013). As P. vivax does 
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not rosette well with reticulocytes, one has to question what prevents the interaction 
between reticulocyte CD236R with the yet to be discovered P. vivax rosetting ligands. 
Based on previous study on characteristics of reticulocytes (Malleret et al., 2013), it is 
possible that the rigid biochemical properties of reticulocytes (reticulocytes are stiffer 
than normocytes) inhibit close bond formation with the P. vivax-infected erythrocytes. 
Close examination of P. vivax rosetting images (especially in Figure 4.5B and 4.12A) 
reveals the tight association between normocytes and infected erythrocytes (indicated by 
the flat face of the biconcave disk to the infected erythrocyte). The globular and stiff 
reticulocytes prevent intimate contact with the infected erythrocytes. Furthermore, 
attempt to promote rosetting by manipulating reticulocytes into direct contact with the P. 
vivax-infected erythrocytes using micropipette technique failed to induce rosetting (Lee 
et al., 2014). 
 
 Another point worth mentioning is the significant reduction, instead of complete 
inhibition of rosetting by the anti-CD236R clone BRIC4 Fab and CD236R-knock down 
erythrocytes. The results from both experiments indicate that the BRIC4 region of 
CD236R plays significant role as one of the coreceptors in rosette formation of P. 
falciparum and P. vivax. Nevertheless, it is definitely not an exclusive rosetting receptor 
in any of the two species studied.  
 
5.4 The biological role of P. vivax and P. falciparum rosetting  
 To date, the roles of rosetting in pathogenesis of malaria remain to be validated. 
The question that remains to be answered for this biological phenomenon is whether it 
confers and advantage to the intra-erythrocytic parasites. The results obtained in this 
research project are inadequate to provide a definite answer to this question. 
Nonetheless, the collected data have shown that rosetting does not directly facilitate 
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reinvasion of P. vivax merozoites upon rupture of schizonts, backed by two lines of 
evidence. 
 
 Firstly, P. vivax infected erythrocytes preferentially forms rosettes with 
normocytes and not reticulocytes. If rosetting was to significantly facilitate merozoite 
reinvasion, the erythrocytes infected with parasites of mature stages should 
preferentially adhere to uninfected reticulocytes, which would subsequently improve the 
invasion success rate by granting proximate and immediate access to reticulocytes, 
which are relatively scarce in the peripheral circulation. However, observations of 
naturally occurring rosettes from fresh isolates and reticulocyte enrichment study in this 
research project clearly show that rosettes favour normocytes instead of reticulocytes. 
Since P. vivax merozoites exclusively invade reticulocytes, there would be little, if no 
advantage for P. vivax-infected erythrocytes to adhere to normocytes, which are not 
receptive to reinvasion. On the other hand, P. falciparum merozoites can invade both 
reticulocytes and normocytes. Therefore, its preferential rosette formation with 
normocytes does not rule out the possibility that rosetting may enhance reinvasion 
success of P. falciparum merozoites. Nevertheless, previous studies have shown that the 
rosette-forming strains of P. falciparum have no invasion advantage over the non-
rosette forming strains (Clough et al., 1998; Deans & Rowe, 2006). Furthermore, 
unpublished data (Asst. Prof. Dr. Bruce Russell, personal communication) from an 
earlier study on P. vivax invasion showed that the rosetting rate within an isolate bears 
no correlation with invasion success. 
 
 The second line of evidence against the “rosette-assisted invasion” hypothesis is 
that P. vivax and P. falciparum start rosetting at early trophozoite stage, which is at least 
24 hours prior to the release of merozoites from the ruptured schizont. While some may 
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suggest that the developing parasite is getting an “early warm up” on the enrolment of 
receptive erythrocytes, such an effort would be futile as the shear forces within host’s 
circulation and physical barriers such as the splenic red pulp would disrupt and 
dissociate rosettes numerous times within the 24 hours-time interval between the 
initiation of rosetting and schizont rupture. Perhaps even more convincingly, the 
gametocytes of P. vivax and P. falciparum have been observed to be involved in rosette 
formation as well. This particular finding is contrary to previous report (Lowe et al., 
1998), which backed the “rosette-assisted invasion” hypothesis with the finding that the 
sexual stages were excluded from rosette formation.  
 
 Clearly, the data from this research project, coupled with data from previous 
studies suggest that rosetting does not directly assist in targeting or invasion of malaria 
parasites into the uninfected host erythrocytes. Therefore, another postulated role of 
rosetting as a “shield” for immune response evasion and protection against harmful 
substances may be the more likely role of rosetting in malaria pathogenesis (Wahlgren 
et al., 1989). Indeed, results from two experiments of this research project (the anti-
malarial drug and human WBCs challenge studies) seem to support this “rosetting 
immune-evasion hypothesis”. From the experiments conducted, rosetting rates of P. 
falciparum and P. vivax isolates were elevated with the presence of anti-malarial drugs 
and human WBCs. 
 
 In the presence of “threats” such as chemicals (e.g. anti-malaria drugs) or host’s 
WBCs, the Plasmodium-infected erythrocytes may be stimulated to form rosettes. The 
rosette may act as a primitive protective shield. Rosette formation will hinder 
phagocytosis of the infected erythrocyte by the host’s phagocytes. Besides, rosette may 
slow down the harmful substances from reaching the infected erythrocytes. In view of 
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such “rosetting-reflex” by the presence of WBCs, rosetting may contribute more 
significantly towards mechanical vascular occlusion in vivo for falciparum malaria cases, 
along with deep vein sequestration. 
 
Based on the results, it is postulated that rosette formation may be an intrinsic, 
reflex-like response by the malaria parasite upon encounter of life-threatening entities. 
Such mechanism may be intended as a “shield-like” protective measure for the parasite, 
albeit not a completely effective one. The findings from this research project serve as 
preliminary evidence for this rosetting role. For future studies, other non-anti-malarial 
drug compounds can be tested. Besides, parasite strains that are not forming rosettes 
under normal physiological condition such as the P. falciparum HB3-HBEC and FCR3-
CSA strains (Adams et al., 2014) can be used for further investigation of this aspect. 
 
 Prior to this research project, there were only a few studies regarding effects of 
anti-malaria drugs or other chemical compounds on rosetting and none of these used P. 
vivax (Udomsangptech et al., 1996; Goldring et al., 1999; Kyriacou et al., 2007). It is 
interesting to point out that the results obtained from the anti-malaria drug exposure 
assays of this research project were different from those of previous studies conducted 
on P. falciparum (Udomsangptech et al., 1996; Goldring et al., 1999). Such discrepancy 
may arise from the difference in research design. In this study, the infected erythrocytes 
were matured until at least 70% of the parasite population reached late trophozoite stage. 
After that, the culture suspension was transferred into the drug plates and incubated for 
two hours prior to rosetting assay. Since rosetting is noted to develop optimally at the 
mature erythrocytic stages, incubation of the parasites with drugs after maturing them 
allows assessment of the effect of drugs on rosetting in a relatively “parasite growth-
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independent” manner. In other words, any observed effect of drugs on rosetting was not 
due to arrested parasite’s growth by the drugs.  
 
 In one of the previous studies (Udomsangpetch et al., 1996), infected 
erythrocytes were incubated with the drugs for a range of 2-24 hours prior to drug-free 
in vitro maturation for another 24-30 hours. Subsequently rosetting development was 
evaluated along the parasite’s erythrocytic maturation. Such design may inhibit 
synthesis machinery of many important proteins within the parasites during the early 
erythrocytic stages, hence causing inhibition of rosette formation. As mentioned in 
previous section, PfEMP1, the rosetting ligand for P. falciparum, is noted to appear on 
the surface of infected erythrocytes from the late ring stage onwards (Gardner et al., 
1996; Kyes et al., 2000; kriek et al., 2003). Therefore, if the protein synthesis of the 
parasite is arrested at its early developmental stage, various biological activities of this 
parasite will be subsequently inhibited. Another study (Goldring et al., 1999) applied 
method similar to that used in this study, albeit with longer incubation period (4 hours). 
Nevertheless, the drug concentrations applied in previous studies were much higher 
than those used in this study. For example, the lowest mefloquine concentration used by 
Goldring et al. was 200 ng/ml (Goldring et al., 1999), whereas the highest mefloquine 
concentration used in this study was 140.25 ng/ml. The mefloquine concentration used 
by Udomsangpetch et al in their in vitro study was 250 ng/ml (Udomsangpetch et al., 
1996). The electrical charges carried by the drug molecules may affect the rosetting 
efficiency of the infected erythrocyte when the drug concentration is higher than a 
certain threshold. Nevertheless, this effect of electrical charges of a compound on 
Plasmodium rosetting remains to be validated.  
 
 
107 
 
CONCLUSION 
From this research project, a novel technique for visualization and 
characterization of reticulocytes and malaria-infected erythrocyte rosettes was 
successfully developed. This convenient and economical technique provides a simple 
and accurate way of conducting reticulocyte characterization on haemoprotozoa-
infected blood samples and malaria rosette related experiments. 
 
Rosetting phenomenon of P. vivax has been studied and characterized. Rosette 
formation is commonly seen in P. vivax, where its development along the parasite 
erythrocytic maturation resembles that of P. falciparum. Nevertheless, P. vivax rosetting 
poses several differences from P. falciparum rosetting. Giant rosettes are more 
commonly found in P. vivax compared to P. falciparum. In addition, gametocytes of P. 
vivax and P. falciparum are found to be involved in rosette formation as well. Unlike P. 
falciparum, cryopreservation affects the rosetting capability of P. vivax isolates. 
 
Human ABO blood group-independent rosetting in P. falciparum and P. vivax 
isolates from the Thai-Myanmar border shows that rosetting phenomenon is a multi-
factorial biological event that involves multiple receptors and varies from one 
geographical strain to another. Unlike P. falciparum, P. vivax rosetting is independent 
of CR1. The BRIC 4 region of CD236R is the newly found rosetting coreceptor for P. 
vivax and P. falciparum. As with P. falciparum, there is likely to be more than one host 
receptor involved in P. vivax rosetting. This finding contributes to the search of P. vivax 
rosetting ligand. 
 
The almost exclusive preference for normocytes in rosetting indicates that 
rosetting does not directly assist merozoite reinvasion of P. vivax. Instead, rosetting is 
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more likely to play a role as protection for the parasitized erythrocytes against external 
harms such as the host’s WBCs and anti-malarial drugs. The high frequency of rosetting 
in patient isolates suggests that it confers P. vivax with a survival advantage. 
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APPENDICES 
Appendix 1 5% Giemsa- wet mounting technique 
• Blood cell suspension of 5% heamatocrit (cell density) is prepared using PBS 
(incomplete McCoy’s and RPMI medium can be used as alternatives to PBS). 
• For 95 µl of cell suspension, 5 µl of filtered Giemsa stock is added, and stained 
for 15 minutes. 
• 7.5 µl of the stained suspension is dropped onto a pre-cleaned glass slide, and 
covered with glass coverslip (22 x 32 mm). 
• The wet mount is examined with light microscope using oil immersion 
magnification.  
 
Appendix 2 NMB reticulocyte staining protocol 
• 1 volume of blood is pipette into a microcentrifuge tube. 
• 1 volume of NMB stain stock is pipette into the blood, and mixed well. 
• The blood suspension is stained for 15 minutes. 
• For traditional smearing method, a thin smear is prepared from the stained blood. 
• For wet mounting method, a 7.5 µl of this stained suspension is used for wet 
mount preparation. 
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Appendix 3 Malaria parasite thawing 
• Cryopreserved blood vial is thawed in 37°C water bath. 
• The volume of cryopreserved sample is measured (volume = X). 
• 0.2 X volume of 12 % NaCl solution is mixed with the blood slowly, on drop by 
drop basis. 
• The well- mixed suspension is left for 5 minutes. 
• 10 X volume of 1.6 % NaCl solution is mixed with the suspension slowly, on 
drop by drop basis. 
• The suspension is centrifuged at 1800 rpm for 5 minutes. 
• Supernatant is removed. 
• 10 X volume of 0.9 % NaCl solution is mixed with the suspension, on drop by 
drop basis. 
• The suspension is centrifuged again at 1800 rpm for 5 minutes. 
• Supernatant is removed. 
• The volume of packed red blood cells is measured for further usage. 
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Appendix 4 Malaria parasite cryopreservation 
• The volume of packed parasite- infected blood cells is measure (volume = X). 
• 0.33 X volume of glycerolyte is mixed with the blood cells slowly, on drop by 
drop basis. 
• The mixture is left for 5 minutes. 
• 1.3 X volume of glycerolyte is mixed with the suspension slowly, on drop by 
drop basis. 
• The mixture is then transferred into cryopreservation vials (around 0.8 – 1.0 ml 
each vial). 
• These vials are placed into a polystyrene box and sealed properly. 
• The box of vials is then left in -80°C freezer overnight. 
• The frozen vials are transferred into liquid nitrogen tank for long time storage. 
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Appendix 5 Concentration technique of erythrocytes infected with Plasmodium 
ring forms 
• Infected blood is filtered using CF 11 column. 
• Blood smear examination is performed. 
• If the parasite population consists of more than 50 % ring forms, this technique 
can be applied. 
• The blood sample is centrifuged at 1800 rpm for 5 minutes. 
• Excessive supernatant is removed and only 5 ml of supernatant is kept. 
• The blood is then mixed well with the left supernatant. 
• The 5 ml suspension is then added slowly onto the 75 % Percoll as gently as 
possible. 
• The sample is centrifuged at 2800 rpm for 15 minutes. 
• The ring band is collected. 
• The efficiency of concentration is then confirmed with a blood smear 
examination. 
• If the yield is successful, the packed red blood cells is then cryopreserved.  
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Appendix 6 Concentration technique of reticulocytes from cord blood 
• Cord blood obtained from donors can be kept for as long as l month prior to this 
technique application. 
• Blood is filtered with CF 11 column twice. 
• The filtered blood can be kept in pure Mc Coy’s medium at 4°C before further 
processing. 
• 5 ml blood of 50 % hematocrit value is prepared. 
• This 5 ml blood is mixed with 6 ml of 65% Percoll in a Falcon tube as gently as 
possible. 
• The mixture is centrifuged at 2800 rpm for 15 minutes. 
• The ring band is collected and resuspended in Mc Coy’s medium. 
• The suspension is centrifuged again at 1800 rpm for 5 minutes. 
• Supernatant is removed, and blood cell pellet is collected. 
• A blood smear from this pellet is examined. 
• The reticulocyte harvest is considered good if the reticulocytes accommodate at 
least 30 % of the whole population. 
• The pellet can then be resuspended in 5 ml of plain McCoy’s medium. 
• If the reticulocyte harvest is not as good, the concentration technique can be 
repeated by combining several low grade harvests prior to the concentration 
technique. 
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Appendix 7 AB serum preparation 
• Blood is drawn from donors with AB blood group, and collected in sterile 50 ml 
Falcon tubes. 
• The blood is left at room temperature overnight to ensure complete coagulation 
of blood. 
• Coagulated blood is centrifuged for 10 minutes at 1800 rpm. 
• Serum is extracted with Pastuer pipettes and collected in new sterile Falcon 
tubes. 
• Transferred serum is heat inactivated at 56 °C for 1 hour. 
• Heat inactivated serum is then aliquoted accordingly into collecting tubes (10 ml 
each). 
• The tubes are sealed. 
• The serum is stored in -20 °C freezer.  
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